SEC EDGAR · 10-Q
10-Q – 2025-10-31 – ttmi-20250929.htm
133190 tecken · 1 HTML-del(ar)
Automatiskt nyckeltalsindex
Detta är sökträffar och textkontext, inte verifierade eller normaliserade redovisningsvärden.
Omsättning
- Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
- Net sales
- (2) Revenues | As of September 29, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations for long‑term contracts was $ 418,620 . The Company expects to recognize revenue on approximately 57 % of the remaining performance obligations for the Company’s long-term contracts over the next 12 months with the remaining amount expected t o be recognized thereafter. | For contracts in which anticipated total costs exceed the total expected revenue, an estimated loss is recognized in the period when identifiable. A provision for the entire amount of the estimated loss is recorded on a cumulative basis. The estimated remaining costs to complete for loss contracts as of September 29, 2025 and December 30, 2024 were $ 32,275 and $ 36,976 , respectively.
- As of September 29, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations for long‑term contracts was $ 418,620 . The Company expects to recognize revenue on approximately 57 % of the remaining performance obligations for the Company’s long-term contracts over the next 12 months with the remaining amount expected t o be recognized thereafter. | For contracts in which anticipated total costs exceed the total expected revenue, an estimated loss is recognized in the period when identifiable. A provision for the entire amount of the estimated loss is recorded on a cumulative basis. The estimated remaining costs to complete for loss contracts as of September 29, 2025 and December 30, 2024 were $ 32,275 and $ 36,976 , respectively. | Revenue recognized for the three quarters ended September 29, 2025 from amounts recorded as contract liabilities as of December 30, 2024 was $ 82,722 . Revenue recognized for the three quarters ended September 30, 2024 from amounts recorded as contract liabilities as of January 1, 2024 was $ 33,331 .
- For contracts in which anticipated total costs exceed the total expected revenue, an estimated loss is recognized in the period when identifiable. A provision for the entire amount of the estimated loss is recorded on a cumulative basis. The estimated remaining costs to complete for loss contracts as of September 29, 2025 and December 30, 2024 were $ 32,275 and $ 36,976 , respectively. | Revenue recognized for the three quarters ended September 29, 2025 from amounts recorded as contract liabilities as of December 30, 2024 was $ 82,722 . Revenue recognized for the three quarters ended September 30, 2024 from amounts recorded as contract liabilities as of January 1, 2024 was $ 33,331 . | Revenue from products and services transferred to customers over time and at a point in time accounted for 96 % and 4 % , respectively, of the Company’s revenue for both the quarter and three quarters ended September 29, 2025 and September 30, 2024.
- Revenue recognized for the three quarters ended September 29, 2025 from amounts recorded as contract liabilities as of December 30, 2024 was $ 82,722 . Revenue recognized for the three quarters ended September 30, 2024 from amounts recorded as contract liabilities as of January 1, 2024 was $ 33,331 . | Revenue from products and services transferred to customers over time and at a point in time accounted for 96 % and 4 % , respectively, of the Company’s revenue for both the quarter and three quarters ended September 29, 2025 and September 30, 2024. | Disaggregated revenue by principal end markets within reportable segments was as follows:
- Revenue from products and services transferred to customers over time and at a point in time accounted for 96 % and 4 % , respectively, of the Company’s revenue for both the quarter and three quarters ended September 29, 2025 and September 30, 2024. | Disaggregated revenue by principal end markets within reportable segments was as follows:
- (1) The end market revenue for the A&D and Commercial reportable segments prior to the quarter ended June 30, 2025 has been recast to reflect certain adjustments to allocations resulting from the segment reorganization. The end market revenue excludes intersegment sales totaling $ 3,469 and $ 9,119 for the quarter and three quarters ended September 29, 2025, respectively, and $ 2,157 and $ 5,646 for the quarter and three quarters ended September 30, 2024, respectively. See Note 4, Segment Inform
Rörelseresultat
- Operating income
- During the quarter ended June 30, 2025, in connection with the Company's change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, the Company’s management finalized its assessment of the Company's operating segments and concluded that the Company now has three reportable segments: A&D, Commercial, and RF&S Components. In prior periods, the Company had two reportable segments: PCB and RF&S Components. As a result, certain prior period amoun | The reportable segments shown below are the Company’s segments for which separate financial information is available and upon which operating results are evaluated by the chief operating decision maker (CODM), who is the President and Chief Executive Officer , to assess performance and to allocate resources. The CODM uses segment operating income to allocate resources such as employees and capital resources for each segment during the Company’s annual budgeting and forecasting process. Total sal | The A&D reportable segment consists of PCBs, value-added assemblies, microelectronics, RF/microwave components and assemblies, and integrated mission systems. These highly engineered electronics products include the manufacture and test of customer‑supplied designs as well as long-term contracts to design, develop, manufacture, and test new products. The products in the A&D reportable segment support surveillance, intelligence, communications, and other critical missions for customers in the aer
- Reconciliations of net sales and segment operating income were as follows:
- Operating Income
- Operating expenses increased $8.1 million to $251.9 million for the three quarters ended September 29, 2025, from $243.8 million for the three quarters ended September 30, 2024, primarily due to the absence of gains on the sale of assets primarily related to the sale of two buildings vacated with the closure of our Anaheim and Santa Clara plants of $14.4 million that occurred in the three quarters ended September 30, 2024, partially offset by the write down of our Hong Kong building of $6.1 mill | Operating Income and Margin Rate | Operating income increased $20.9 million to $71.9 million for the quarter ended September 29, 2025, from $51.0 million for the quarter ended September 30, 2024. Operating margin rate increased to 9.6% for the quarter ended September 29, 2025, from 8.3% for the quarter ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses .
- Operating Income and Margin Rate | Operating income increased $20.9 million to $71.9 million for the quarter ended September 29, 2025, from $51.0 million for the quarter ended September 30, 2024. Operating margin rate increased to 9.6% for the quarter ended September 29, 2025, from 8.3% for the quarter ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses . | Operating income increased $76.9 million to $183.9 million for the three quarters ended September 29, 2025, from $107.0 million for the three quarters ended September 30, 2024. Operating margin rate increased to 8.6% for the three quarters ended September 29, 2025, from 6.0% for the three quarters ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses .
- Operating income increased $20.9 million to $71.9 million for the quarter ended September 29, 2025, from $51.0 million for the quarter ended September 30, 2024. Operating margin rate increased to 9.6% for the quarter ended September 29, 2025, from 8.3% for the quarter ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses . | Operating income increased $76.9 million to $183.9 million for the three quarters ended September 29, 2025, from $107.0 million for the three quarters ended September 30, 2024. Operating margin rate increased to 8.6% for the three quarters ended September 29, 2025, from 6.0% for the three quarters ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses . | Total Other Expense, Net
- During the quarter ended June 30, 2025, in connection with our change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, our management finalized its assessment of our operating segments and concluded that we now have three reportable segments: A&D, Commercial, and RF&S Components. As a result, certain prior period amounts have been reclassified to conform with this new presentation. See Part I, Item 1, Note 4, Segment Information , of the | Selected segment financial highlights, with reconciliations to operating income, are presented in the table below:
Periodens resultat
- Net income
- Adjustments to reconcile net income to net cash provided by operating activities:
- Our principal sources of liquidity have been cash provided by operations, the issuance of debt, and borrowings under our revolving credit facilities. Our principal uses of cash have been to finance capital expenditures, finance acquisitions, fund working capital requirements, repay debt obligations, and repurchase common stock. We anticipate that financing capital expenditures, financing acquisitions, funding working capital requirements, servicing debt, and repurchasing common stock will be the | Cash flow provided by operating activities during the first three quarters of 2025 was $229.0 million as compared to cash flow provided by operating activities of $150.8 million in the same period in 2024. The increase in cash flow was primarily due to an increase in net income of $75.6 million. | Net cash used in investing activities during the first three quarters of 2025 was $222.7 million, primarily resulting from the use of $223.2 million for net purchases of property, plant, and equipment and other assets. Net cash used in investing activities during the first three quarters of 2024 was $93.4 million, primarily resulting from the use of $129.7 million for purchases of property, plant, and equipment and other assets. This was partially offset by the receipt of $29.6 million of procee
Resultat per aktie
- Earnings per share:
- Basic earnings per share
- Diluted earnings per share
- (9) Earnings Per Share, Share Repurchase Program, and Accumulated Other Comprehensive Loss | Earnings Per Share
- (9) Earnings Per Share, Share Repurchase Program, and Accumulated Other Comprehensive Loss | Earnings Per Share | The reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share is as follows:
- Earnings Per Share | The reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share is as follows:
- PRUs and RSUs to pur chase 161 and 220 shares of common stock for the quarter and three quarters ended September 29, 2025 , respectively, and PRUs, RSUs, and stock options to purchase 144 and 166 shares of common stock for the quarter and three quarters ended September 30, 2024, respectively, were not included in the computation of diluted earnings per share because the impact would be anti-dilutive. The PRUs would have had an anti-dilutive impact because the performance conditions had not been
Kassaflöde
- Net unrealized gain (loss) on cash flow hedges:
- Unrealized gain (loss) on effective cash flow | hedges during the period, net
- Supplemental cash flow information:
- Cash flow hedges
- Our principal sources of liquidity have been cash provided by operations, the issuance of debt, and borrowings under our revolving credit facilities. Our principal uses of cash have been to finance capital expenditures, finance acquisitions, fund working capital requirements, repay debt obligations, and repurchase common stock. We anticipate that financing capital expenditures, financing acquisitions, funding working capital requirements, servicing debt, and repurchasing common stock will be the | Cash flow provided by operating activities during the first three quarters of 2025 was $229.0 million as compared to cash flow provided by operating activities of $150.8 million in the same period in 2024. The increase in cash flow was primarily due to an increase in net income of $75.6 million. | Net cash used in investing activities during the first three quarters of 2025 was $222.7 million, primarily resulting from the use of $223.2 million for net purchases of property, plant, and equipment and other assets. Net cash used in investing activities during the first three quarters of 2024 was $93.4 million, primarily resulting from the use of $129.7 million for purchases of property, plant, and equipment and other assets. This was partially offset by the receipt of $29.6 million of procee
Likvida medel
- Cash and cash equivalents
- Effect of foreign currency exchange rates on cash and cash equivalents
- Net (decrease) increase in cash and cash equivalents
- Cash and cash equivalents at beginning of period
- Cash and cash equivalents at end of period
- (3) Significant Customers and Concentration of Credit Risk | Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents and accounts receivable. | The Company had cash and cash equivalents held by its foreign subsidiaries of $ 196,603 and $ 207,909 as of September 29, 2025 and December 30, 2024, respectively. The Company maintains its cash and cash equivalents with major financial institutions and such balances exceed Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on cash and cash equivalents.
- Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents and accounts receivable. | The Company had cash and cash equivalents held by its foreign subsidiaries of $ 196,603 and $ 207,909 as of September 29, 2025 and December 30, 2024, respectively. The Company maintains its cash and cash equivalents with major financial institutions and such balances exceed Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on cash and cash equivalents. | In the normal course of business, the Company extends credit to its customers. Some customers to whom the Company extends credit are located outside the United States. The Company performs ongoing credit evaluations of customers, does not require collateral, and considers the credit risk profile of the entity from which the receivable is due in further evaluating collection risk. As of September 29, 2025 , one customer accounted for 14 % of the Compa ny's accounts receivable. There were no custo
- The fair value of the long-term debt was estimated based on quoted market prices or discounting the debt over its life using current market rates for similar debt as of September 29, 2025 and December 30, 2024, which are considered Level 2 inputs. | As of September 29, 2025 and December 30, 2024, the Company’s other financial instruments included cash and cash equivalents, accounts receivable, contract assets, accounts payable, and contract liabilities. The carrying amount of these instruments approximates fair value. | The majority of the Company’s non-financial assets and liabilities, which include goodwill, intangible assets, inventories, and property, plant, and equipment, are not required to be carried at fair value on a recurring basis. However, if certain triggering events occur (or as indicated by the annual test in the case of goodwill) such that a non-financial instrument is required to be evaluated for impairment, based upon a comparison of the non-financial instrument’s fair value to its carrying va
Nettoskuld
- Adjustments to reconcile net income to net cash provided by operating activities:
- Net cash provided by operating activities
- Net cash used in investing activities
- Net cash used in financing activities
- Cash flow provided by operating activities during the first three quarters of 2025 was $229.0 million as compared to cash flow provided by operating activities of $150.8 million in the same period in 2024. The increase in cash flow was primarily due to an increase in net income of $75.6 million. | Net cash used in investing activities during the first three quarters of 2025 was $222.7 million, primarily resulting from the use of $223.2 million for net purchases of property, plant, and equipment and other assets. Net cash used in investing activities during the first three quarters of 2024 was $93.4 million, primarily resulting from the use of $129.7 million for purchases of property, plant, and equipment and other assets. This was partially offset by the receipt of $29.6 million of procee | Net cash used in financing activities during the first three quarters of 2025 was $19.2 million, reflecting the use of $17.9 million for repurchases of our common stock and $2.8 million for the repayment of long-term debt borrowings, less customer deposits of $1.5 million. Net cash used in financing activities during the first three quarters of 2024 was $38.2 million, reflecting the use of $34.5 million for repurchases of common stock, $8.7 million for the repayment of long-term debt borrowings,
- Net cash used in investing activities during the first three quarters of 2025 was $222.7 million, primarily resulting from the use of $223.2 million for net purchases of property, plant, and equipment and other assets. Net cash used in investing activities during the first three quarters of 2024 was $93.4 million, primarily resulting from the use of $129.7 million for purchases of property, plant, and equipment and other assets. This was partially offset by the receipt of $29.6 million of procee | Net cash used in financing activities during the first three quarters of 2025 was $19.2 million, reflecting the use of $17.9 million for repurchases of our common stock and $2.8 million for the repayment of long-term debt borrowings, less customer deposits of $1.5 million. Net cash used in financing activities during the first three quarters of 2024 was $38.2 million, reflecting the use of $34.5 million for repurchases of common stock, $8.7 million for the repayment of long-term debt borrowings, | As of September 29, 2025, we had cash and cash equivalents of approximately $491.1 million, of which approximately $196.6 million was held by our foreign subsidiaries, primarily in China, and $199.4 million of available borrowing capacity under our revolving credit facilities. Should we choose to remit cash to the United States from our foreign locations, we may incur tax obligations which would reduce the amount of cash ultimately available to the United States. However, we believe there would
Eget kapital
- Consolidated Condensed Statements of Stockholders' Equity for the three quarters ended September 29, 2025 and September 30, 2024
- LIABILITIES AND STOCKHOLDERS' EQUITY
- Total stockholders’ equity
- Total liabilities and stockholders' equity
- TTM TECHNOLOGIES, INC. | Consolidated Condensed Statements of Stockholders’ Equity | For the Three Quarters Ended September 29, 2025 and September 30, 2024
Antal aktier
- 113,161 shares issued as of September 29, 2025 and December 30, 2024, | respectively; 103,331 and 101,997 shares outstanding as of | September 29, 2025 and December 30, 2024, respectively
- Basic weighted average shares
- Share Repurchase Program | On May 8, 2025, the Company's Board of Directors authorized a new share repurchase program (2025 Repurchase Program) , under which the Company may repurchase up to $ 100,000 in value of the Company’s outstanding shares of common stock from time to time through May 7, 2027 . The Company’s previous two-year repurchase program expired on May 3, 2025 . The Company may repurchase shares through open market purchases, privately‑negotiated transactions, or otherwise in accordance with applicable federa
- Total Number of Shares of Common Stock to be Sold (3)
- (3) Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the trading plan.
- (4) Rule 10b5-1 trading arrangement that is intended to provide for “eligible sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from vesting of RSUs or PRUs. The number of shares subject to covered RSUs or PRUs that will be sold to satisfy applicable tax withholding obligations upon vesting is not currently determinable as the number will vary based on the market price of our common stock an
Antal anställda
- During the quarter ended June 30, 2025, in connection with the Company's change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, the Company’s management finalized its assessment of the Company's operating segments and concluded that the Company now has three reportable segments: A&D, Commercial, and RF&S Components. In prior periods, the Company had two reportable segments: PCB and RF&S Components. As a result, certain prior period amoun | The reportable segments shown below are the Company’s segments for which separate financial information is available and upon which operating results are evaluated by the chief operating decision maker (CODM), who is the President and Chief Executive Officer , to assess performance and to allocate resources. The CODM uses segment operating income to allocate resources such as employees and capital resources for each segment during the Company’s annual budgeting and forecasting process. Total sal | The A&D reportable segment consists of PCBs, value-added assemblies, microelectronics, RF/microwave components and assemblies, and integrated mission systems. These highly engineered electronics products include the manufacture and test of customer‑supplied designs as well as long-term contracts to design, develop, manufacture, and test new products. The products in the A&D reportable segment support surveillance, intelligence, communications, and other critical missions for customers in the aer
Bruttomarginal
- Gross margin
- Gross Profit and Margin Rate | Gross profit increased $26.8 million to $156.7 million for the quarter ended September 29, 2025, from $129.9 million for the quarter ended September 30, 2024, primarily due to higher sales. Gross margin rate decreased slightly to 20.8% for the quarter ended September 29, 2025, from 21.1% for the quarter ended September 30, 2024. This decrease was primarily due to ramp‑up costs incurred in the third quarter of 2025 in connection with our fabrication plant in Penang, Malaysia as compared to the th | Gross profit increased $85.0 million to $435.8 million for the three quarters ended September 29, 2025, from $350.8 million for the three quarters ended September 30, 2024, primarily due to higher sales. Gross margin rate increased to 20.4% for the three quarters ended September 29, 2025, from 19.6% for the three quarters ended September 30, 2024. The increase was primarily due to improved operational execution, favorable product mix, and increased volume of PCB shipments as compared to the same
- Gross profit increased $26.8 million to $156.7 million for the quarter ended September 29, 2025, from $129.9 million for the quarter ended September 30, 2024, primarily due to higher sales. Gross margin rate decreased slightly to 20.8% for the quarter ended September 29, 2025, from 21.1% for the quarter ended September 30, 2024. This decrease was primarily due to ramp‑up costs incurred in the third quarter of 2025 in connection with our fabrication plant in Penang, Malaysia as compared to the th | Gross profit increased $85.0 million to $435.8 million for the three quarters ended September 29, 2025, from $350.8 million for the three quarters ended September 30, 2024, primarily due to higher sales. Gross margin rate increased to 20.4% for the three quarters ended September 29, 2025, from 19.6% for the three quarters ended September 30, 2024. The increase was primarily due to improved operational execution, favorable product mix, and increased volume of PCB shipments as compared to the same | Operating Expenses
Fulltext
10-Q false --12-29 458 355 319 313 466 328 323 314 Q3 277 307 305 307 388 0001116942 326 http://fasb.org/srt/2025#ChiefExecutiveOfficerMember http://fasb.org/srt/2025#PresidentMember 0001116942 us-gaap:TransferredOverTimeMember 2024-01-02 2024-09-30 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:SeniorNotesDueTwoThousandTwentyNineMember 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 0001116942 us-gaap:TreasuryStockCommonMember 2024-01-02 2024-04-01 0001116942 us-gaap:CommonStockMember 2024-07-01 0001116942 ttmi:RobertFarrellMember 2025-07-01 2025-09-29 0001116942 us-gaap:OtherDebtSecuritiesMember 2024-12-30 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 us-gaap:OperatingSegmentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember 2024-01-02 2024-09-30 0001116942 us-gaap:OperatingSegmentsMember 2024-01-02 2024-09-30 0001116942 us-gaap:IntersegmentEliminationMember ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 us-gaap:CommonStockMember 2024-01-02 2024-04-01 0001116942 us-gaap:RetainedEarningsMember 2024-09-30 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-29 0001116942 us-gaap:TransferredAtPointInTimeMember 2024-01-02 2024-09-30 0001116942 ttmi:DataCenterComputingMember 2024-07-02 2024-09-30 0001116942 us-gaap:OperatingSegmentsMember ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 ttmi:AssetBackedLendingRevolvingLoansMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 0001116942 us-gaap:CorporateNonSegmentMember 2025-07-01 2025-09-29 0001116942 us-gaap:OperatingSegmentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 ttmi:UsAssetBasedLendingRevolvingLoanDueTwoThousandTwentyFourMember 2024-12-30 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:IntersegmentEliminationMember 2024-01-02 2024-09-30 0001116942 srt:WeightedAverageMember 2024-12-31 2025-09-29 0001116942 ttmi:AutomotiveComponentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 ttmi:NetworkingCommunicationMember 2024-12-31 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-02 2024-09-30 0001116942 ttmi:AsiaAssetBasedLendingRevolvingLoanDueJuneTwoThousandTwentyEightMember 2024-12-31 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:IntersegmentEliminationMember 2024-12-31 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember 2024-01-02 2024-09-30 0001116942 us-gaap:IntersegmentEliminationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember 2024-12-31 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 2025-06-30 0001116942 2025-03-31 0001116942 ttmi:DanielLBoehleMember 2025-07-01 2025-09-29 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-04-02 2024-07-01 0001116942 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001116942 ttmi:AsiaAssetBasedLendingRevolvingLoanDueJuneTwoThousandTwentyEightMember 2024-12-30 0001116942 us-gaap:CorporateNonSegmentMember 2024-07-02 2024-09-30 0001116942 us-gaap:OperatingSegmentsMember 2024-12-31 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-01-02 2024-04-01 0001116942 ttmi:NetworkingCommunicationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 ttmi:NetworkingCommunicationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 us-gaap:TransferredOverTimeMember 2025-07-01 2025-09-29 0001116942 2024-04-01 0001116942 2023-05-03 2023-05-03 0001116942 ttmi:ThomasTEdmanMember ttmi:Rule10B51TradingPlanTwoMember 2025-07-01 2025-09-29 0001116942 us-gaap:IntersegmentEliminationMember 2024-01-02 2024-09-30 0001116942 ttmi:NetworkingCommunicationMember ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 2024-07-01 0001116942 us-gaap:TreasuryStockCommonMember 2025-03-31 0001116942 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-09-29 0001116942 ttmi:ThomasTEdmanMember ttmi:Rule10B51TradingPlanOneMember 2025-07-01 2025-09-29 0001116942 us-gaap:TreasuryStockCommonMember 2024-04-02 2024-07-01 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:TermLoanDueTwoThousandThirtyMember 2025-09-29 0001116942 us-gaap:CommonStockMember 2025-03-31 0001116942 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-29 0001116942 us-gaap:CustomerRelationshipsMember 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001116942 ttmi:TechnologyMember 2024-12-30 0001116942 ttmi:AutomotiveComponentsMember ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:OperatingSegmentsMember 2024-12-31 2025-09-29 0001116942 ttmi:AutomotiveComponentsMember ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 ttmi:SeniorNotesDueTwoThousandTwentyNineMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 2025-03-31 0001116942 us-gaap:IntersegmentEliminationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 us-gaap:IntersegmentEliminationMember ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 2024-12-31 2025-03-31 0001116942 us-gaap:CommonStockMember 2024-12-31 2025-03-31 0001116942 2025-05-08 2025-05-08 0001116942 ttmi:OtherThanUnitedStatesAndTaiwanMember 2025-07-01 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember 2024-07-02 2024-09-30 0001116942 us-gaap:SalesRevenueNetMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember us-gaap:CustomerConcentrationRiskMember 2024-01-02 2024-09-30 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:OtherLoanMember 2025-09-29 0001116942 us-gaap:IntersegmentEliminationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 ttmi:AssetBackedLendingRevolvingLoansMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-12-30 0001116942 ttmi:AutomotiveComponentsMember 2024-07-02 2024-09-30 0001116942 ttmi:AutomotiveComponentsMember 2025-07-01 2025-09-29 0001116942 ttmi:NetworkingCommunicationMember 2025-07-01 2025-09-29 0001116942 ttmi:TermLoanDueTwoThousandThirtyMember 2024-12-31 2025-09-29 0001116942 ttmi:OtherLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-29 0001116942 us-gaap:IntersegmentEliminationMember 2024-07-02 2024-09-30 0001116942 ttmi:TermLoanDueTwoThousandThirtyMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-12-30 0001116942 2024-01-02 2024-12-30 0001116942 us-gaap:CorporateNonSegmentMember 2024-12-31 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember 2024-12-31 2025-09-29 0001116942 ttmi:DanielJWeberMember 2025-07-01 2025-09-29 0001116942 ttmi:NetworkingCommunicationMember 2024-07-02 2024-09-30 0001116942 us-gaap:TreasuryStockCommonMember 2024-01-01 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:OtherLoanMember 2024-12-30 0001116942 country:US 2024-12-31 2025-09-29 0001116942 us-gaap:TreasuryStockCommonMember 2024-04-01 0001116942 ttmi:Rule10B51TradingPlanOneMember ttmi:ShawnPowersMember 2025-07-01 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:OperatingSegmentsMember 2024-07-02 2024-09-30 0001116942 us-gaap:TransferredOverTimeMember 2024-07-02 2024-09-30 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 us-gaap:SalesRevenueNetMember 2024-07-02 2024-09-30 0001116942 ttmi:NetworkingCommunicationMember ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 us-gaap:CommonStockMember 2024-04-01 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-12-30 0001116942 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001116942 us-gaap:TransferredOverTimeMember 2024-12-31 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:IntersegmentEliminationMember 2025-07-01 2025-09-29 0001116942 ttmi:TermLoanDueTwoThousandThirtyMember 2025-09-29 0001116942 ttmi:PerformanceBasedRestrictedStockUnitsRestrictedStockUnitsAndStockOptionsMember 2024-01-02 2024-09-30 0001116942 ttmi:DataCenterComputingMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 2025-09-30 2025-09-29 0001116942 ttmi:ThomasClapproodMember 2025-07-01 2025-09-29 0001116942 us-gaap:CommonStockMember 2024-01-01 0001116942 ttmi:UsAssetBasedLendingRevolvingLoanDueTwoThousandTwentyFourMember 2025-09-29 0001116942 ttmi:CommercialMember 2024-12-30 0001116942 us-gaap:RetainedEarningsMember 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-02 2024-07-01 0001116942 2025-09-29 0001116942 us-gaap:RetainedEarningsMember 2025-03-31 0001116942 country:US 2024-07-02 2024-09-30 0001116942 ttmi:TechnologyMember 2025-09-29 0001116942 us-gaap:RetainedEarningsMember 2025-06-30 0001116942 ttmi:AerospaceAndDefenseMember 2025-09-29 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:OperatingSegmentsMember 2024-01-02 2024-09-30 0001116942 ttmi:Rule10B51TradingPlanOneMember ttmi:DouglasLSoderMember 2025-07-01 2025-09-29 0001116942 2024-01-02 2024-04-01 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 0001116942 us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-02 2024-12-30 0001116942 ttmi:CatherineAGridleyMember 2025-07-01 2025-09-29 0001116942 ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-09-29 0001116942 ttmi:TermLoanDueTwoThousandThirtyMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001116942 ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 us-gaap:IntersegmentEliminationMember 2025-07-01 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 0001116942 us-gaap:SalesRevenueNetMember 2024-01-02 2024-09-30 0001116942 ttmi:Rule10B51TradingPlanOneMember ttmi:DouglasLSoderMember 2025-09-29 0001116942 us-gaap:TransferredAtPointInTimeMember 2024-07-02 2024-09-30 0001116942 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-30 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 us-gaap:IntersegmentEliminationMember ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-30 0001116942 us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 2025-09-29 0001116942 ttmi:DataCenterComputingMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 ttmi:SeniorNotesDueTwoThousandTwentyNineMember 2024-12-31 2025-09-29 0001116942 ttmi:AutomotiveComponentsMember 2024-01-02 2024-09-30 0001116942 ttmi:StevenSpotoMember 2025-07-01 2025-09-29 0001116942 ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 us-gaap:OperatingSegmentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 us-gaap:CommonStockMember 2025-06-30 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 0001116942 ttmi:AerospaceAndDefenseMember 2025-07-01 2025-09-29 0001116942 ttmi:AerospaceAndDefenseMember 2024-12-30 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-12-30 0001116942 us-gaap:OtherDebtSecuritiesMember 2025-09-29 0001116942 ttmi:DataCenterComputingMember 2025-07-01 2025-09-29 0001116942 ttmi:AutomotiveComponentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-31 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember 2024-07-02 2024-09-30 0001116942 us-gaap:CommonStockMember 2024-04-02 2024-07-01 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-02 2024-04-01 0001116942 us-gaap:OperatingSegmentsMember 2024-07-02 2024-09-30 0001116942 ttmi:AsiaAssetBasedLendingRevolvingLoanDueJuneTwoThousandTwentyEightMember 2025-09-29 0001116942 us-gaap:SalesRevenueNetMember 2024-12-31 2025-09-29 0001116942 country:US 2025-07-01 2025-09-29 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:TermLoanDueTwoThousandThirtyMember 2024-12-30 0001116942 ttmi:SeniorNotesDueTwoThousandTwentyNineMember 2024-12-30 0001116942 ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-12-30 0001116942 ttmi:AerospaceAndDefenseMember us-gaap:IntersegmentEliminationMember 2024-07-02 2024-09-30 0001116942 country:CN 2025-09-29 0001116942 us-gaap:TreasuryStockCommonMember 2024-07-01 0001116942 ttmi:JamesPWalshMember 2025-07-01 2025-09-29 0001116942 2024-09-30 0001116942 country:TW 2024-01-02 2024-09-30 0001116942 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-29 0001116942 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001116942 ttmi:AutomotiveComponentsMember ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 us-gaap:IntersegmentEliminationMember ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 ttmi:DataCenterComputingMember ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 ttmi:OtherLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-12-30 0001116942 us-gaap:RetainedEarningsMember 2024-01-02 2024-04-01 0001116942 us-gaap:AdditionalPaidInCapitalMember 2025-09-29 0001116942 us-gaap:TreasuryStockCommonMember 2024-09-30 0001116942 ttmi:OtherThanUnitedStatesAndTaiwanMember 2024-12-31 2025-09-29 0001116942 ttmi:SeniorNotesDueTwoThousandTwentyNineMember 2025-09-29 0001116942 ttmi:TermLoanDueTwoThousandThirtyMember 2024-12-30 0001116942 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-29 0001116942 us-gaap:RetainedEarningsMember 2024-04-02 2024-07-01 0001116942 us-gaap:SalesRevenueNetMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember us-gaap:CustomerConcentrationRiskMember 2024-07-02 2024-09-30 0001116942 us-gaap:CommonStockMember 2024-12-30 0001116942 us-gaap:RetainedEarningsMember 2024-12-31 2025-03-31 0001116942 ttmi:NetworkingCommunicationMember ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 us-gaap:OperatingSegmentsMember ttmi:CommercialMember 2024-01-02 2024-09-30 0001116942 ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 ttmi:AutomotiveComponentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-09-29 0001116942 ttmi:Rule10B51TradingPlanTwoMember ttmi:ShawnPowersMember 2025-07-01 2025-09-29 0001116942 ttmi:PerformanceBasedRestrictedStockUnitsAndRestrictedStockUnitsMember 2025-07-01 2025-09-29 0001116942 us-gaap:TreasuryStockCommonMember 2024-12-31 2025-03-31 0001116942 us-gaap:IntersegmentEliminationMember 2024-12-31 2025-09-29 0001116942 2024-04-02 2024-07-01 0001116942 ttmi:SeniorNotesDueTwoThousandTwentyNineMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-12-30 0001116942 us-gaap:CommonStockMember 2025-09-29 0001116942 2024-12-30 0001116942 country:TW 2024-12-31 2025-09-29 0001116942 ttmi:OtherThanUnitedStatesAndTaiwanMember 2024-01-02 2024-09-30 0001116942 ttmi:NetworkingCommunicationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:SeniorNotesDueTwoThousandTwentyNineMember 2024-12-30 0001116942 2025-07-01 2025-09-29 0001116942 ttmi:PerformanceBasedRestrictedStockUnitsRestrictedStockUnitsAndStockOptionsMember 2024-07-02 2024-09-30 0001116942 country:CN 2024-12-30 0001116942 us-gaap:OperatingSegmentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-29 0001116942 us-gaap:AccumulatedTranslationAdjustmentMember 2025-09-29 0001116942 country:TW 2025-07-01 2025-09-29 0001116942 us-gaap:CommonStockMember 2025-07-01 2025-09-29 0001116942 us-gaap:IntersegmentEliminationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 us-gaap:CustomerRelationshipsMember 2024-12-30 0001116942 us-gaap:RetainedEarningsMember 2024-04-01 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:AssetBackedLendingRevolvingLoansMember 2024-12-30 0001116942 us-gaap:AccountsReceivableMember 2024-01-02 2024-12-30 0001116942 2024-01-02 2024-09-30 0001116942 us-gaap:TreasuryStockCommonMember 2025-06-30 0001116942 ttmi:DaleKnechtMember 2025-07-01 2025-09-29 0001116942 ttmi:DataCenterComputingMember 2024-12-31 2025-09-29 0001116942 us-gaap:RetainedEarningsMember 2024-07-02 2024-09-30 0001116942 us-gaap:TreasuryStockCommonMember 2025-09-29 0001116942 us-gaap:TreasuryStockCommonMember 2024-12-30 0001116942 us-gaap:OperatingSegmentsMember ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 us-gaap:TransferredAtPointInTimeMember 2024-12-31 2025-09-29 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 2025-03-31 0001116942 ttmi:DataCenterComputingMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-12-30 0001116942 us-gaap:SalesRevenueNetMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-29 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-07-02 2024-09-30 0001116942 ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 us-gaap:CommonStockMember 2024-07-02 2024-09-30 0001116942 ttmi:AutomotiveComponentsMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 2024-01-01 0001116942 ttmi:DataCenterComputingMember ttmi:CommercialMember 2025-07-01 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember 2025-07-01 2025-09-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-09-29 0001116942 2025-05-08 0001116942 us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-29 0001116942 ttmi:ThomasTEdmanMember ttmi:Rule10B51TradingPlanTwoMember 2025-09-29 0001116942 ttmi:DataCenterComputingMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 2025-04-01 2025-06-30 0001116942 ttmi:OtherThanUnitedStatesAndTaiwanMember 2024-07-02 2024-09-30 0001116942 ttmi:ShawnPowersMember ttmi:Rule10B51TradingPlanTwoMember 2025-09-29 0001116942 ttmi:NetworkingCommunicationMember 2024-01-02 2024-09-30 0001116942 ttmi:DataCenterComputingMember ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 us-gaap:AccountsReceivableMember 2024-12-31 2025-09-29 0001116942 ttmi:Rule10B51TradingPlanTwoMember ttmi:DouglasLSoderMember 2025-07-01 2025-09-29 0001116942 us-gaap:SalesRevenueNetMember 2025-07-01 2025-09-29 0001116942 us-gaap:RetainedEarningsMember 2024-01-01 0001116942 2024-12-31 2025-09-29 0001116942 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-12-30 0001116942 ttmi:CommercialMember 2025-09-29 0001116942 us-gaap:SalesRevenueNetMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 2025-09-29 0001116942 ttmi:NetworkingCommunicationMember ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 us-gaap:TransferredAtPointInTimeMember 2025-07-01 2025-09-29 0001116942 country:US 2024-01-02 2024-09-30 0001116942 country:TW 2024-07-02 2024-09-30 0001116942 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001116942 ttmi:NetworkingCommunicationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-01-02 2024-09-30 0001116942 2025-10-29 0001116942 ttmi:MedicalIndustrialInstrumentationMember ttmi:RadioFrequencyAndSpecialtyComponentsMember 2024-07-02 2024-09-30 0001116942 us-gaap:CommonStockMember 2024-09-30 0001116942 ttmi:PerformanceBasedRestrictedStockUnitsAndRestrictedStockUnitsMember 2024-12-31 2025-09-29 0001116942 us-gaap:CarryingReportedAmountFairValueDisclosureMember ttmi:AssetBackedLendingRevolvingLoansMember 2025-09-29 0001116942 us-gaap:OperatingSegmentsMember ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001116942 ttmi:DataCenterComputingMember 2024-01-02 2024-09-30 0001116942 ttmi:AutomotiveComponentsMember 2024-12-31 2025-09-29 0001116942 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001116942 ttmi:RadioFrequencyAndSpecialtyComponentsMember 2025-07-01 2025-09-29 0001116942 us-gaap:CorporateNonSegmentMember 2024-01-02 2024-09-30 0001116942 2024-07-02 2024-09-30 0001116942 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001116942 us-gaap:RetainedEarningsMember 2024-12-30 0001116942 ttmi:AutomotiveComponentsMember ttmi:CommercialMember 2024-07-02 2024-09-30 0001116942 ttmi:DataCenterComputingMember ttmi:CommercialMember 2024-12-31 2025-09-29 0001116942 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-30 0001116942 us-gaap:RetainedEarningsMember 2024-07-01 xbrli:pure xbrli:shares iso4217:USD xbrli:shares ttmi:Customer iso4217:USD ttmi:Country UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to____________ Commission File Number: 000-31285 TTM TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 91-1033443 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 200 East Sandpointe , Suite 400 , Santa Ana , California 92707 (Address of principal executive offices) ( 714 ) 327-3000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock , $0.001 par value TTMI Nasdaq Global Select Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☑ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑ As of October 29, 2025, there were outstanding 103,330,725 sh ares of the registrant’s Common Stock, $0.001 par value. TTM TECHNOLOGIES, INC. Form 10-Q For the Quarter Ended September 29, 2025 TABLE OF CONTENTS Page PART I: FINANCIAL INFORMATION 3 Item 1. Financial Statements (unaudited) 3 Consolidated Condensed Balance Sheets as of September 29, 2025 and December 30, 2024 3 Consolidated Condensed Statements of Operations for the quarter and three quarters ended September 29, 2025 and September 30, 2024 4 Consolidated Condensed Statements of Comprehensive Income for the quarter and three quarters ended September 29, 2025 and September 30, 2024 5 Consolidated Condensed Statements of Stockholders' Equity for the three quarters ended September 29, 2025 and September 30, 2024 6 Consolidated Condensed Statements of Cash Flows for the three quarters ended September 29, 2025 and September 30, 2024 7 Notes to Consolidated Condensed Financial Statements 8 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3. Quantitative and Qualitative Disclosures About Market Risk 27 Item 4. Controls and Procedures 27 PART II: OTHER INFORMATION 28 Item 1. Legal Proceedings 28 Item 1A. Risk Factors 28 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 Item 3. Defaults Upon Senior Securities 28 Item 4. Mine Safety Disclosures 28 Item 5. Other Information 28 Item 6. Exhibits 30 SIGNATURES 31 2 PART I. FINANCI AL INFORMATION Item 1. Financial Sta tements (unaudited) TTM TECHNOLOGIES, INC. Consolidated Condens ed Balance Sheets As of September 29, 2025 and December 30, 2024 As of September 29, 2025 December 30, 2024 (Unaudited) (In thousands, except par value) ASSETS Current assets: Cash and cash equivalents $ 491,120 $ 503,932 Accounts receivable, net 500,147 448,611 Contract assets 446,967 381,382 Inventories 253,687 224,985 Prepaid expenses and other current assets 63,694 47,834 Total current assets 1,755,615 1,606,744 Property, plant, and equipment, net 992,193 869,957 Operating lease right-of-use assets 80,905 78,252 Goodwill 670,135 670,135 Definite-lived intangibles, net 164,146 191,819 Deposits and other non-current assets 57,534 55,587 Total assets $ 3,720,528 $ 3,472,494 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Short-term debt, including current portion of long-term debt $ 3,810 $ 3,795 Accounts payable 506,386 406,221 Contract liabilities 149,368 170,915 Accrued salaries, wages, and benefits 131,093 108,149 Other current liabilities 114,546 119,974 Total current liabilities 905,203 809,054 Long-term debt, net of discount and issuance costs 912,835 914,359 Operating lease liabilities 84,534 77,509 Other long-term liabilities 116,508 107,748 Total long-term liabilities 1,113,877 1,099,616 Commitments and contingencies (Note 11) Equity: Common stock, $ 0.001 par value; 300,000 shares authorized, 115,195 and 113,161 shares issued as of September 29, 2025 and December 30, 2024, respectively; 103,331 and 101,997 shares outstanding as of September 29, 2025 and December 30, 2024, respectively 115 113 Treasury stock – common stock at cost; 11,864 and 11,164 shares as of September 29, 2025 and December 30, 2024, respectively ( 175,445 ) ( 157,570 ) Additional paid-in capital 940,325 910,741 Retained earnings 965,185 838,422 Accumulated other comprehensive loss ( 28,732 ) ( 27,882 ) Total stockholders’ equity 1,701,448 1,563,824 Total liabilities and stockholders' equity $ 3,720,528 $ 3,472,494 See accompanying notes to consolidated condensed financial statements. 3 TTM TECHNOLOGIES, INC. Consolidated Condensed St atements of Operations For the Quarter and Three Quarters Ended September 29, 2025 and September 30, 2024 For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (Unaudited) (In thousands, except per share data) Net sales $ 752,736 $ 616,538 $ 2,132,025 $ 1,791,788 Cost of goods sold 596,000 486,650 1,696,208 1,440,954 Gross profit 156,736 129,888 435,817 350,834 Operating expenses: Selling and marketing 21,796 19,961 64,383 60,053 General and administrative 48,598 42,567 142,091 124,841 Research and development 7,038 8,054 22,111 23,922 Amortization of definite-lived intangibles 6,889 6,951 20,666 28,636 Restructuring charges 509 1,393 2,631 6,367 Total operating expenses 84,830 78,926 251,882 243,819 Operating income 71,906 50,962 183,935 107,015 Other (expense) income: Interest expense ( 10,399 ) ( 11,768 ) ( 32,958 ) ( 36,311 ) Other, net 306 ( 14,177 ) ( 2,648 ) ( 1,086 ) Total other expense, net ( 10,093 ) ( 25,945 ) ( 35,606 ) ( 37,397 ) Income before income taxes 61,813 25,017 148,329 69,618 Income tax provision ( 8,758 ) ( 10,706 ) ( 21,566 ) ( 18,489 ) Net income $ 53,055 $ 14,311 $ 126,763 $ 51,129 Earnings per share: Basic earnings per share $ 0.51 $ 0.14 $ 1.24 $ 0.50 Diluted earnings per share 0.50 0.14 1.21 0.49 See accompanying notes to consolidated condensed financial statements. 4 TTM TECHNOLOGIES, INC. Consolidated Condensed Statements of Comprehensive Income For the Quarter and Three Quarters Ended September 29, 2025 and September 30, 2024 For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (Unaudited) (In thousands) Net income $ 53,055 $ 14,311 $ 126,763 $ 51,129 Other comprehensive income (loss), net of tax: Pension obligation — — 1,174 — Foreign currency translation 49 325 208 ( 533 ) Net unrealized gain (loss) on cash flow hedges: Unrealized gain (loss) on effective cash flow hedges during the period, net 335 ( 3,905 ) ( 1,439 ) 835 Amounts realized in the statement of operations, net ( 522 ) ( 851 ) ( 793 ) ( 2,579 ) Net ( 187 ) ( 4,756 ) ( 2,232 ) ( 1,744 ) Other comprehensive loss, net of tax ( 138 ) ( 4,431 ) ( 850 ) ( 2,277 ) Comprehensive income, net of tax $ 52,917 $ 9,880 $ 125,913 $ 48,852 See accompanying notes to consolidated condensed financial statements. 5 TTM TECHNOLOGIES, INC. Consolidated Condensed Statements of Stockholders’ Equity For the Three Quarters Ended September 29, 2025 and September 30, 2024 Common Stock Treasury Stock Additional Paid-In Retained Accumulated Other Comprehensive Total Stockholders' Shares Amount Shares Amount Capital Earnings Loss Equity (Unaudited) (In thousands) Balance, December 30, 2024 113,161 $ 113 ( 11,164 ) $ ( 157,570 ) $ 910,741 $ 838,422 $ ( 27,882 ) $ 1,563,824 Net income — — — — — 32,178 — 32,178 Other comprehensive income — — — — — — 87 87 Issuance of common stock for performance-based restricted stock units 305 — — — — — — — Issuance of common stock for restricted stock units 20 — — — — — — — Repurchases of common stock — — ( 700 ) ( 17,875 ) — — — ( 17,875 ) Stock-based compensation — — — — 8,787 — — 8,787 Balance, March 31, 2025 113,486 $ 113 ( 11,864 ) $ ( 175,445 ) $ 919,528 $ 870,600 $ ( 27,795 ) $ 1,587,001 Net income — — — — — 41,530 — 41,530 Other comprehensive loss — — — — — — ( 799 ) ( 799 ) Issuance of common stock for restricted stock units 1,687 2 — — ( 2 ) — — — Stock-based compensation — — — — 9,188 — — 9,188 Balance, June 30, 2025 115,173 $ 115 ( 11,864 ) $ ( 175,445 ) $ 928,714 $ 912,130 $ ( 28,594 ) $ 1,636,920 Net income — — — — — 53,055 — 53,055 Other comprehensive loss — — — — — — ( 138 ) ( 138 ) Issuance of common stock for restricted stock units 22 — — — — — — — Stock-based compensation — — — — 11,611 — — 11,611 Balance, September 29, 2025 115,195 $ 115 ( 11,864 ) $ ( 175,445 ) $ 940,325 $ 965,185 $ ( 28,732 ) $ 1,701,448 Common Stock Treasury Stock Additional Paid-In Retained Accumulated Other Comprehensive Total Stockholders' Shares Amount Shares Amount Capital Earnings Loss Equity (Unaudited) (In thousands) Balance, January 1, 2024 111,282 $ 111 ( 9,174 ) $ ( 123,091 ) $ 880,963 $ 782,123 $ ( 29,067 ) $ 1,511,039 Net income — — — — — 10,466 — 10,466 Other comprehensive income — — — — — — 2,150 2,150 Issuance of common stock for performance-based restricted stock units 227 1 — — ( 1 ) — — — Issuance of common stock for restricted stock units 41 — — — — — — — Repurchases of common stock — — ( 600 ) ( 9,334 ) — — — ( 9,334 ) Stock-based compensation — — — — 6,787 — — 6,787 Balance, April 1, 2024 111,550 $ 112 ( 9,774 ) $ ( 132,425 ) $ 887,749 $ 792,589 $ ( 26,917 ) $ 1,521,108 Net income — — — — — 26,352 — 26,352 Other comprehensive income — — — — — — 4 4 Issuance of common stock for restricted stock units 1,559 1 — — ( 1 ) — — — Repurchases of common stock — — ( 1,390 ) ( 25,145 ) — — — ( 25,145 ) Stock-based compensation — — — — 6,580 — — 6,580 Balance, July 1, 2024 113,109 $ 113 ( 11,164 ) $ ( 157,570 ) $ 894,328 $ 818,941 $ ( 26,913 ) $ 1,528,899 Net income — — — — — 14,311 — 14,311 Other comprehensive loss — — — — — — ( 4,431 ) ( 4,431 ) Issuance of common stock for restricted stock units 23 — — — — — — — Stock-based compensation — — — — 8,330 — — 8,330 Balance, September 30, 2024 113,132 $ 113 ( 11,164 ) $ ( 157,570 ) $ 902,658 $ 833,252 $ ( 31,344 ) $ 1,547,109 See accompanying notes to consolidated condensed financial statements. 6 TTM TECHNOLOGIES, INC. Consolidated Condensed S tatements of Cash Flows For the Three Quarters Ended September 29, 2025 and September 30, 2024 For the Three Quarters Ended September 29, 2025 September 30, 2024 (Unaudited) (In thousands) Cash flows from operating activities: Net income $ 126,763 $ 51,129 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation of property, plant, and equipment 82,135 78,709 Amortization of definite-lived intangible assets 27,673 35,642 Amortization of debt discount and issuance costs 1,609 1,517 Deferred income taxes 1,461 ( 1,180 ) Stock-based compensation 29,586 21,697 Other 5,512 2,194 Changes in operating assets and liabilities: Accounts receivable, net ( 51,536 ) ( 9,328 ) Contract assets ( 65,585 ) ( 70,618 ) Inventories ( 28,702 ) ( 14,838 ) Prepaid expenses and other assets ( 11,667 ) ( 2,236 ) Accounts payable 102,253 34,698 Contract liabilities ( 21,547 ) 11,860 Accrued salaries, wages, and benefits 22,944 14,055 Other liabilities 8,053 ( 2,461 ) Net cash provided by operating activities 228,952 150,840 Cash flows from investing activities: Net purchases of property, plant, and equipment and other assets ( 223,176 ) ( 129,709 ) Proceeds from sale of property, plant, and equipment and other assets 489 29,599 Proceeds from sale of Shanghai E-MS (SH E-MS) property — 6,737 Other — ( 76 ) Net cash used in investing activities ( 222,687 ) ( 93,449 ) Cash flows from financing activities: Repurchases of common stock ( 17,875 ) ( 34,479 ) Repayment of long-term debt borrowings ( 2,845 ) ( 8,730 ) Customer deposits 1,500 — Proceeds from long-term debt borrowings — 6,105 Payment of debt issuance costs — ( 1,113 ) Net cash used in financing activities ( 19,220 ) ( 38,217 ) Effect of foreign currency exchange rates on cash and cash equivalents 143 118 Net (decrease) increase in cash and cash equivalents ( 12,812 ) 19,292 Cash and cash equivalents at beginning of period 503,932 450,208 Cash and cash equivalents at end of period $ 491,120 $ 469,500 Supplemental cash flow information: Cash paid, net for interest $ 39,807 $ 42,646 Cash paid, net for income taxes 19,426 15,196 Supplemental disclosure of non-cash investing activities: Property, plant, and equipment recorded in accounts payable and other current liabilities $ 62,561 $ 83,934 Cashless rollover of debt — 340,395 See accompanying notes to consolidated condensed financial statements. 7 TTM TECHNOLOGIES, INC. Notes to Consolidated Conde nsed Financial Statements (Unaudited) (Dollars and shares in thousands, except per share data) (1) Nature of Operations and Basis of Presentation TTM Technologies, Inc. (the Company or TTM) is a leading global manufacturer of technology products, including mission systems, radio frequency (RF) components, RF microwave/microelectronic assemblies, and technologically advanced printed circuit boards (PCBs). The Company provides time-to-market and volume production of advanced technology products and offers a one-stop design, engineering, and manufacturing solution to customers. This solution allows the Company to align technology developments with the diverse needs of the Company’s customers and to enable them to reduce the time required to develop new products and bring them to market. The Company serves a diversified customer base in various markets throughout the world, including aerospace and defense, data center computing, automotive, medical, industrial, and instrumentation, and networking. The Company’s customers include original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, original design manufacturers (ODMs), distributors, and government agencies (both domestic and allied foreign governments). The accompanying unaudited consolidated condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s most recent Annual Report on Form 10-K. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated condensed financial statements and accompanying notes. Due, in part, to the conflicts between Russia and Ukraine, as well as other global regions and the imposition of, or changes to, tariffs by the United States as well as retaliatory tariffs or measures by other countries, the global economy and financial markets have been volatile in recent periods. As such, the Company has considered information available to it as of the date of issuance of these consolidated condensed financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision to the carrying value of its assets or liabilities. The actual results the Company experienced may differ materially and adversely from its estimates. The Company uses a 52/53 week fiscal calendar with the fourth quarter ending on the Monday nearest December 31. Recently Issued Accounting Standards Not Yet Adopted In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2025-06, Targeted Improvements to the Accounting for Internal-Use Software , which amends the existing standard to remove all references to prescriptive and sequential software development project stages. Under this guidance, eligible software development costs will begin capitalization when management has authorized and committed to funding the software project, and it is probable that the project will be completed and the software will be used to perform the function intended. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The guidance may be applied on a prospective basis, a modified basis, or a retrospective basis. The Company is currently evaluating the timing of the adoption and the impact of this ASU on its consolidated financial statements and related disclosures. In July 2025, the FASB issued ASU 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets , which provides a practical expedient to measure credit losses on accounts receivable and contract assets. The ASU is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the timing of the adoption and the impact of this ASU on its consolidated financial statements and related disclosures. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses , which requires disclosure in the notes to the financial statements of specified information about certain costs and expenses. In January 2025, the FASB issued ASU 2025-01, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date , which amends the effective date of ASU 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption of ASU 2024-03 is permitted. ASU 2024-03 should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures, but expects additional disclosures upon adoption. 8 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The update will be effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements not yet issued or made available for issuance. The Company will adopt ASU 2023-09 in its 2025 fiscal year Form 10-K. This ASU will impact only the Company's disclosures with no impacts to the results of operations, cash flows, and financial condition. (2) Revenues As of September 29, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations for long‑term contracts was $ 418,620 . The Company expects to recognize revenue on approximately 57 % of the remaining performance obligations for the Company’s long-term contracts over the next 12 months with the remaining amount expected t o be recognized thereafter. For contracts in which anticipated total costs exceed the total expected revenue, an estimated loss is recognized in the period when identifiable. A provision for the entire amount of the estimated loss is recorded on a cumulative basis. The estimated remaining costs to complete for loss contracts as of September 29, 2025 and December 30, 2024 were $ 32,275 and $ 36,976 , respectively. Revenue recognized for the three quarters ended September 29, 2025 from amounts recorded as contract liabilities as of December 30, 2024 was $ 82,722 . Revenue recognized for the three quarters ended September 30, 2024 from amounts recorded as contract liabilities as of January 1, 2024 was $ 33,331 . Revenue from products and services transferred to customers over time and at a point in time accounted for 96 % and 4 % , respectively, of the Company’s revenue for both the quarter and three quarters ended September 29, 2025 and September 30, 2024. Disaggregated revenue by principal end markets within reportable segments was as follows: For the Quarter Ended September 29, 2025 September 30, 2024 Aerospace and Defense (A&D) Commercial RF and Specialty Components (RF&S Components) Total A&D Commercial RF&S Components Total (In thousands) End Markets (1) : Aerospace and Defense $ 333,556 $ — $ — $ 333,556 $ 277,604 $ — $ — $ 277,604 Automotive — 79,355 — 79,355 — 86,773 — 86,773 Data Center Computing — 175,302 33 175,335 — 121,767 201 121,968 Medical/Industrial/Instrumentation — 107,289 1,128 108,417 — 87,968 579 88,547 Networking — 46,790 9,283 56,073 — 32,681 8,965 41,646 Total $ 333,556 $ 408,736 $ 10,444 $ 752,736 $ 277,604 $ 329,189 $ 9,745 $ 616,538 For the Three Quarters Ended September 29, 2025 September 30, 2024 A&D Commercial RF&S Components Total A&D Commercial RF&S Components Total (In thousands) End Markets (1) : Aerospace and Defense $ 966,066 $ — $ — $ 966,066 $ 828,908 $ — $ — $ 828,908 Automotive — 232,133 — 232,133 — 239,681 — 239,681 Data Center Computing — 460,291 979 461,270 — 359,680 323 360,003 Medical/Industrial/Instrumentation — 299,397 3,046 302,443 — 249,532 2,035 251,567 Networking — 144,826 25,287 170,113 — 86,940 24,689 111,629 Total $ 966,066 $ 1,136,647 $ 29,312 $ 2,132,025 $ 828,908 $ 935,833 $ 27,047 $ 1,791,788 (1) The end market revenue for the A&D and Commercial reportable segments prior to the quarter ended June 30, 2025 has been recast to reflect certain adjustments to allocations resulting from the segment reorganization. The end market revenue excludes intersegment sales totaling $ 3,469 and $ 9,119 for the quarter and three quarters ended September 29, 2025, respectively, and $ 2,157 and $ 5,646 for the quarter and three quarters ended September 30, 2024, respectively. See Note 4, Segment Information , for further information. 9 (3) Significant Customers and Concentration of Credit Risk Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents and accounts receivable. The Company had cash and cash equivalents held by its foreign subsidiaries of $ 196,603 and $ 207,909 as of September 29, 2025 and December 30, 2024, respectively. The Company maintains its cash and cash equivalents with major financial institutions and such balances exceed Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on cash and cash equivalents. In the normal course of business, the Company extends credit to its customers. Some customers to whom the Company extends credit are located outside the United States. The Company performs ongoing credit evaluations of customers, does not require collateral, and considers the credit risk profile of the entity from which the receivable is due in further evaluating collection risk. As of September 29, 2025 , one customer accounted for 14 % of the Compa ny's accounts receivable. There were no customers that accounted for 10 % or more of the Company's accounts receivable as of December 30, 2024. The Company’s customers include both OEMs and EMS companies. The Company’s OEM customers often direct a significant portion of their purchases through EMS companies. While the Company’s customers include both OEM and EMS providers, the Company measures customer concentration based on OEM companies, as they are the ultimate end customers. For the quarter and three quarters ended September 29, 2025 , two customers collectively accounted for approximately 23 % and 22 % of the Company's net sales, respectively. For the quarter and three quarters ended September 30, 2024, one customer accounted for approximately 11 % of the Company's net sales. (4) Segment Information During the quarter ended June 30, 2025, in connection with the Company's change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, the Company’s management finalized its assessment of the Company's operating segments and concluded that the Company now has three reportable segments: A&D, Commercial, and RF&S Components. In prior periods, the Company had two reportable segments: PCB and RF&S Components. As a result, certain prior period amounts have been reclassified to conform with this new presentation. The reportable segments shown below are the Company’s segments for which separate financial information is available and upon which operating results are evaluated by the chief operating decision maker (CODM), who is the President and Chief Executive Officer , to assess performance and to allocate resources. The CODM uses segment operating income to allocate resources such as employees and capital resources for each segment during the Company’s annual budgeting and forecasting process. Total sales and operating profit by segment include intersegment sales which are generally recorded at cost-plus a specified fee or at a negotiated fixed price. Separate segment asset measures are not used as a basis for the CODM to evaluate the performance of or to allocate resources to the segments. The A&D reportable segment consists of PCBs, value-added assemblies, microelectronics, RF/microwave components and assemblies, and integrated mission systems. These highly engineered electronics products include the manufacture and test of customer‑supplied designs as well as long-term contracts to design, develop, manufacture, and test new products. The products in the A&D reportable segment support surveillance, intelligence, communications, and other critical missions for customers in the aerospace and defense industry. The Commercial reportable segment consists of PCBs using customer-supplied engineering and design plans supporting customers in the automotive, medical, industrial, and instrumentation, networking, and data center computing end markets. The RF&S Components reportable segment consists of TTM designed RF components for commercial customers in the telecommunications, industrial, and instrumentation markets, as well as commercial off-the-shelf (COTS) components for certain aerospace and defense customers. 10 Reconciliations of net sales and segment operating income were as follows: For the Quarter Ended September 29, 2025 A&D Commercial RF&S Components Eliminations Total (In thousands, except margin rates) Net sales $ 333,556 $ 408,736 $ 10,444 $ — $ 752,736 Intersegment sales 3,285 184 — ( 3,469 ) — Segment sales $ 336,841 $ 408,920 $ 10,444 $ ( 3,469 ) $ 752,736 Net Sales Cost of Goods Sold Operating Expenses Operating Income Operating Margin A&D $ 336,841 $ ( 255,033 ) $ ( 28,924 ) $ 52,884 15.7 % Commercial 408,920 ( 330,183 ) ( 18,706 ) 60,031 14.7 RF&S Components 10,444 ( 5,032 ) ( 2,286 ) 3,126 29.9 Total segment 756,205 ( 590,248 ) ( 49,916 ) 116,041 15.3 Eliminations ( 3,469 ) — Unallocated amounts: Restructuring ( 509 ) Acquisition-related and other charges ( 15 ) Stock-based compensation ( 11,611 ) Other corporate expenses ( 22,775 ) Amortization of definite-lived intangibles ( 9,225 ) Consolidated $ 752,736 71,906 9.6 % Interest expense ( 10,399 ) Other, net 306 Income before income taxes $ 61,813 For the Quarter Ended September 30, 2024 A&D Commercial RF&S Components Eliminations Total (In thousands, except margin rates) Net sales $ 277,604 $ 329,189 $ 9,745 $ — $ 616,538 Intersegment sales 1,929 193 35 ( 2,157 ) — Segment sales $ 279,533 $ 329,382 $ 9,780 $ ( 2,157 ) $ 616,538 Net Sales Cost of Goods Sold Operating Expenses Operating Income Operating Margin A&D $ 279,533 $ ( 211,536 ) $ ( 27,718 ) $ 40,279 14.4 % Commercial 329,382 ( 262,147 ) ( 16,130 ) 51,105 15.5 RF&S Components 9,780 ( 4,871 ) ( 2,483 ) 2,426 24.8 Total segment 618,695 ( 478,554 ) ( 46,331 ) 93,810 15.2 Eliminations ( 2,157 ) — Unallocated amounts: Restructuring ( 1,393 ) Acquisition-related and other charges ( 2,867 ) Stock-based compensation ( 8,330 ) Other corporate expenses ( 20,972 ) Amortization of definite-lived intangibles ( 9,286 ) Consolidated $ 616,538 50,962 8.3 % Interest expense ( 11,768 ) Other, net ( 14,177 ) Income before income taxes $ 25,017 11 For the Three Quarters Ended September 29, 2025 A&D Commercial RF&S Components Eliminations Total (In thousands, except margin rates) Net sales $ 966,066 $ 1,136,647 $ 29,312 $ — $ 2,132,025 Intersegment sales 8,487 602 30 ( 9,119 ) — Segment sales $ 974,553 $ 1,137,249 $ 29,342 $ ( 9,119 ) $ 2,132,025 Net Sales Cost of Goods Sold Operating Expenses Operating Income Operating Margin A&D $ 974,553 $ ( 745,008 ) $ ( 90,602 ) $ 138,943 14.3 % Commercial 1,137,249 ( 916,920 ) ( 56,580 ) 163,749 14.4 RF&S Components 29,342 ( 14,665 ) ( 7,096 ) 7,581 25.8 Total segment 2,141,144 ( 1,676,593 ) ( 154,278 ) 310,273 14.5 Eliminations ( 9,119 ) — Unallocated amounts: Restructuring ( 2,631 ) Acquisition-related and other charges ( 15 ) Stock-based compensation ( 29,586 ) Other corporate expenses ( 66,433 ) Amortization of definite-lived intangibles ( 27,673 ) Consolidated $ 2,132,025 183,935 8.6 % Interest expense ( 32,958 ) Other, net ( 2,648 ) Income before income taxes $ 148,329 For the Three Quarters Ended September 30, 2024 A&D Commercial RF&S Components Eliminations Total (In thousands, except margin rates) Net sales $ 828,908 $ 935,833 $ 27,047 $ — $ 1,791,788 Intersegment sales 4,890 607 149 ( 5,646 ) — Segment sales $ 833,798 $ 936,440 $ 27,196 $ ( 5,646 ) $ 1,791,788 Net Sales Cost of Goods Sold Operating Expenses Operating Income Operating Margin A&D $ 833,798 $ ( 648,883 ) $ ( 84,663 ) $ 100,252 12.0 % Commercial 936,440 ( 755,231 ) ( 50,351 ) 130,858 14.0 RF&S Components 27,196 ( 13,861 ) ( 7,196 ) 6,139 22.6 Total segment 1,797,434 ( 1,417,975 ) ( 142,210 ) 237,249 13.2 Eliminations ( 5,646 ) — Unallocated amounts: Restructuring ( 6,367 ) Gain on sale of property, plant, and equipment 14,420 Acquisition-related and other charges ( 12,939 ) Stock-based compensation ( 21,697 ) Other corporate expenses ( 68,009 ) Amortization of definite-lived intangibles ( 35,642 ) Consolidated $ 1,791,788 107,015 6.0 % Interest expense ( 36,311 ) Other, net ( 1,086 ) Income before income taxes $ 69,618 12 Amortization of definite-lived intangibles relates to the A&D, Commercial, and RF&S Components reportable segments, but is not reviewed separately by the CODM. For the quarter and three quarters ended September 29, 2025, amortization expense of $ 2,336 and $ 7,007 , respectively, is included in cost of goods sold for the A&D reportable segment. For the quarter and three quarters ended September 30, 2024, amortization expense of $ 2,335 and $ 7,006 , respectively, is included in cost of goods sold for the A&D reportable segment. Depreciation expense by reportable segment was as follows: For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (In thousands) A&D $ 7,985 $ 8,868 $ 25,718 $ 27,882 Commercial 17,536 14,938 50,881 42,902 RF&S Components 453 404 1,319 1,290 Segment total 25,974 24,210 77,918 72,074 Corporate 1,606 3,620 4,217 6,635 Total $ 27,580 $ 27,830 $ 82,135 $ 78,709 The Company markets and sells its products in approximately 50 countries. For the quarter and three quarters ended September 29, 2025, the Company did not conduct business in any country other than the United States in which its net sales in that country exceeded 10% of the Company’s total net sales. For the quarter and three quarters ended September 30, 2024 , net sales in Taiwan also exceeded 10 % of the Company’s total net sales. Net sales are attributed to countries by the invoiced location and were as follows: For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (In thousands) United States $ 407,222 $ 316,508 $ 1,146,649 $ 926,241 Taiwan 62,384 63,607 167,396 206,462 Other 283,130 236,423 817,980 659,085 Total net sales $ 752,736 $ 616,538 $ 2,132,025 $ 1,791,788 13 (5) Composition of Certain Consolidated Condensed Financial Statement Captions As of September 29, 2025 December 30, 2024 (In thousands) Inventories: Raw materials $ 198,073 $ 178,066 Work-in-process 50,840 45,580 Finished goods 4,774 1,339 Inventories $ 253,687 $ 224,985 Property, plant, and equipment, net: Land and land-use rights $ 70,075 $ 69,788 Buildings and improvements 554,679 515,773 Machinery and equipment 1,181,531 1,116,658 Furniture and fixtures and other 11,492 11,115 Construction-in-progress 156,982 75,502 Property, plant, and equipment, gross 1,974,759 1,788,836 Less: Accumulated depreciation ( 982,566 ) ( 918,879 ) Property, plant, and equipment, net $ 992,193 $ 869,957 Other current liabilities: Income taxes payable $ 22,395 $ 15,919 Sales return and allowances 12,668 10,777 Accrued facility operating costs 11,000 8,925 Warranty 10,223 7,685 Housing fund 8,515 7,927 Operating leases 8,326 7,556 Interest 3,867 9,054 Accrued professional fees 3,212 3,606 Other 34,340 48,525 Other current liabilities $ 114,546 $ 119,974 Other long-term liabilities: Deferred income taxes $ 42,835 $ 41,362 Customer deposits 30,105 28,390 Finance leases 15,916 11,985 Other 27,652 26,011 Other long-term liabilities $ 116,508 $ 107,748 14 (6) Goodwill and Definite-lived Intangibles Goodwill In connection with the Company’s assessment of its operating segments, effective during the quarter ended June 30, 2025, the Company determined that its operating segments were also its reporting units and reallocated its PCB goodwill between A&D and Commercial based on the estimated relative fair values of the reporting units. In connection with the reallocation of goodwill, management performed a goodwill impairment assessment for each segment and concluded no impairment indicators as of June 30, 2025. Goodwill by reportable segment was as follows: A&D Commercial RF&S Components Total (In thousands) As of September 29, 2025 and December 30, 2024 Goodwill $ 256,199 $ 382,636 $ 177,200 $ 816,035 Accumulated impairment losses — — ( 145,900 ) ( 145,900 ) Carrying amount $ 256,199 $ 382,636 $ 31,300 $ 670,135 Definite-lived Intangibles The components of definite-lived intangibles were as follows: Gross Amount Accumulated Amortization Net Carrying Amount Weighted Average Amortization Period (In thousands) (In years) As of September 29, 2025 Customer relationships $ 323,500 $ ( 182,376 ) $ 141,124 11.8 Technology 66,650 ( 43,628 ) 23,022 8.2 Total $ 390,150 $ ( 226,004 ) $ 164,146 As of December 30, 2024 Customer relationships $ 323,500 $ ( 161,710 ) $ 161,790 11.8 Technology 66,650 ( 36,621 ) 30,029 8.2 Total $ 390,150 $ ( 198,331 ) $ 191,819 Definite-lived intangibles are amortized using the straight-line method of amortization over the useful life. Amortization expense was $ 9,225 and $ 27,673 for the quarter and three quarters ended September 29, 2025, respectively, and $ 9,286 and $ 35,642 for the quarter and three quarters ended September 30, 2024, respectively. For the quarter and three quarters ended September 29, 2025, $ 2,336 and $ 7,007 , respectively, of amortization expense was included in cost of goods sold. For the quarter and three quarters ended September 30, 2024, $ 2,335 and $ 7,006 , respectively, of amortization expense was included in cost of goods sold. Estimated aggregate amortization for definite-lived intangible assets for the next five years and thereafter is as follows: (In thousands) Remaining 2025 $ 9,224 2026 36,897 2027 34,543 2028 30,997 2029 22,355 Thereafter 30,130 Total $ 164,146 15 (7) Long-term Debt and Letters of Credit Long-term debt was as follows: As of September 29, 2025 December 30, 2024 Interest Rate Principal Outstanding Interest Rate Principal Outstanding (In thousands, except interest rates) Senior Notes due March 2029 4.00 % $ 500,000 4.00 % $ 500,000 Term Loan due May 2030 6.38 343,035 6.59 345,634 Asia ABL Revolving Loan due June 2028 5.43 80,000 5.64 80,000 Other 5.99 2,065 5.99 2,311 Total debt 925,100 927,945 Less: Unamortized debt issuance costs ( 5,957 ) ( 6,951 ) Less: Unamortized debt discount ( 2,498 ) ( 2,840 ) Subtotal 916,645 918,154 Less: Current maturities ( 3,810 ) ( 3,795 ) Long-term debt, less current maturities $ 912,835 $ 914,359 Debt Covenants Borrowings under the Senior Notes due 2029 and Term Loan Facility due 2030 (Term Loan Facility) are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments. Under the occurrence of certain events, the U.S. Asset-Based Lending Credit Agreement (U.S. ABL) and Asia Asset-Based Lending Credit Agreement (Asia ABL) (collectively, the ABL Revolving Loans) are subject to various financial covenants, including leverage and fixed-charge coverage ratios. Debt Issuance Costs and Debt Discount Remaining unamortized debt issuance costs and debt discount were as follows: As of September 29, 2025 December 30, 2024 Debt Issuance Costs Debt Discount Effective Interest Rate Debt Issuance Costs Debt Discount Effective Interest Rate (In thousands, except interest rates) Senior Notes due March 2029 $ 2,799 $ — 4.18 % $ 3,362 $ — 4.18 % Term Loan due May 2030 3,158 2,498 8.01 3,589 2,840 8.01 Total $ 5,957 $ 2,498 $ 6,951 $ 2,840 The above debt issuance costs and debt discount are recorded as a reduction of the debt and are amortized into interest expense using an effective interest rate over the duration of the debt. Remaining unamortized debt issuance costs for the ABL Revolving Loans of $ 966 and $ 1,239 as of September 29, 2025 and December 30, 2024, respectively, are included in deposits and other non-current assets and are amortized to interest expense over the duration of the ABL Revolving Loans using the straight-line method of amortization. As of September 29, 2025, the remaining weighted average amortization period for all unamortized debt issuance costs and debt discount wa s 4.1 yea rs. (8) Income Taxes The Company’s effective tax rate is impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits, and deductions available to the Company as well as changes in valuation allowances and certain non-deductible items. No tax benefit was recorded on the losses incurred in certain foreign jurisdictions as a result of corresponding increases in the valuation allowances in these jurisdictions. During the quarter and three quarters ended September 29, 2025, the Company’s effective tax rate was impacted by a net discrete benefit of $ 37 and $ 3,321 , respectively, and the One Big Beautiful Bill Act (OBBBA) tax impact, as discussed below. The net discrete benefit was primarily related to the deduction of stock‑based compensation, partially offset by accruals for potential assessments and uncertain tax positions in various jurisdictions. 16 The Company has various foreign subsidiaries formed or acquired to conduct or support its business outside the U.S. The Company expects its earnings attributable to most foreign subsidiaries may be repatriated back to the U.S. and so a deferred tax liability has been recorded for foreign withholding taxes and the estimated federal/state tax impact on any repatriation. For those other companies with earnings currently being reinvested outside of the U.S., no deferred tax liability on undistributed earnings has been recorded. OBBBA On July 4, 2025, the OBBBA was enacted, introducing amendments to U.S. tax laws with various effective dates from 2025 to 2027. The OBBBA includes provisions such as the permanent extension of certain provisions of the Tax Cuts and Jobs Act that were set to expire at the end of 2025 and modifications to the international tax framework. Because Topic 740 requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted, the Company’s tax provisions for the quarter and three quarters ended September 29, 2025 incorporated the estimated effects of the tax law changes including the accelerated depreciation of qualified property and the immediate expensing of U.S. research and development expenditure paid or incurred for tax years beginning after December 31, 2024. The Company recorded a $ 5,186 b enefit from the decrease in the U.S. valuation allowance resulting from the OBBBA impact to its deferred tax assets. (9) Earnings Per Share, Share Repurchase Program, and Accumulated Other Comprehensive Loss Earnings Per Share The reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share is as follows: For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (In thousands, except per share amounts) Net income $ 53,055 $ 14,311 $ 126,763 $ 51,129 Basic weighted average shares 103,321 101,958 102,337 101,704 Dilutive effect of performance-based restricted stock units (PRUs), restricted stock units (RSUs), and stock options 2,491 1,870 2,724 2,224 Diluted shares 105,812 103,828 105,061 103,928 Earnings per share: Basic earnings per share $ 0.51 $ 0.14 $ 1.24 $ 0.50 Diluted earnings per share 0.50 0.14 1.21 0.49 PRUs and RSUs to pur chase 161 and 220 shares of common stock for the quarter and three quarters ended September 29, 2025 , respectively, and PRUs, RSUs, and stock options to purchase 144 and 166 shares of common stock for the quarter and three quarters ended September 30, 2024, respectively, were not included in the computation of diluted earnings per share because the impact would be anti-dilutive. The PRUs would have had an anti-dilutive impact because the performance conditions had not been met during the applicable quarter and three quarters. The RSUs and stock options would have had an anti-dilutive impact because the total expected proceeds under the treasury stock method or the options’ exercise prices were greater than the average market price of common stock during the applicable quarter and three quarters. Share Repurchase Program On May 8, 2025, the Company's Board of Directors authorized a new share repurchase program (2025 Repurchase Program) , under which the Company may repurchase up to $ 100,000 in value of the Company’s outstanding shares of common stock from time to time through May 7, 2027 . The Company’s previous two-year repurchase program expired on May 3, 2025 . The Company may repurchase shares through open market purchases, privately‑negotiated transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended (Exchange Act), which sets certain restrictions on the method, timing, price, and volume of open market stock repurchases. In addition, the Company adopted one trading plan in accordance with Rule 10b5-1 of the Exchange Act to facilitate certain purchases that may be effected under the share repurchase program. The timing, manner, price, and amount of any repurchases will be determined at the Company’s discretion, and the share repurchase program may be suspended, terminated, or modified at any time for any reason. The repurchase program does not obligate the Company to acquire any specific number of shares. 17 During the quarter ended September 29, 2025, the Comp any did no t repurchase any shares. During the three quarters ended September 29, 2025 , the Company repurchased 700 shares of common stock for a total cost of $ 17,875 (including commissions) under the Company’s previous repurchase program. As of September 29, 2025, the remaining amount in value available to be repurchased under the 2025 Repurchase Program was $ 100,000 . Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss, n et of tax, were as follows: As of September 29, 2025 December 30, 2024 (In thousands) Foreign currency translation $ ( 33,549 ) $ ( 33,757 ) Pension obligation 4,786 3,612 Cash flow hedges 31 2,263 Total $ ( 28,732 ) $ ( 27,882 ) (10) Fair Value Measures The Company measures at fair value its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The carrying amount and estimated fair value of the Company’s financial instruments were as follows: As of September 29, 2025 December 30, 2024 Carrying Amount Fair Value Carrying Amount Fair Value (In thousands) Derivative assets, current $ 1,666 $ 1,666 $ 1,765 $ 1,765 Derivative assets, non-current — — 1,326 1,326 Derivative liabilities, current — — 667 667 Derivative liabilities, non-current 429 429 — — Senior Notes due March 2029 497,201 481,695 496,638 464,325 Term Loan due May 2030 337,379 344,966 339,205 346,930 ABL Revolving Loans 80,000 80,000 80,000 80,000 Other loan 2,065 2,065 2,311 2,311 The fair value of the derivative instruments was determined using pricing models developed based on the 1-month Chicago Mercantile Exchange (CME) Term Secured Overnight Financing Rate (SOFR) swap rate and other observable market data, including quoted market prices, as appropriate using Level 2 inputs. The values were adjusted to reflect non-performance risk of both the counterparty and the Company, as necessary. The fair value of the long-term debt was estimated based on quoted market prices or discounting the debt over its life using current market rates for similar debt as of September 29, 2025 and December 30, 2024, which are considered Level 2 inputs. As of September 29, 2025 and December 30, 2024, the Company’s other financial instruments included cash and cash equivalents, accounts receivable, contract assets, accounts payable, and contract liabilities. The carrying amount of these instruments approximates fair value. The majority of the Company’s non-financial assets and liabilities, which include goodwill, intangible assets, inventories, and property, plant, and equipment, are not required to be carried at fair value on a recurring basis. However, if certain triggering events occur (or as indicated by the annual test in the case of goodwill) such that a non-financial instrument is required to be evaluated for impairment, based upon a comparison of the non-financial instrument’s fair value to its carrying value, an impairment is recorded to reduce the carrying value to the fair value, if the carrying value exceeds the fair value. 18 (11) Commitments and Contingencies Legal Matters The Company is subject to various legal matters, which it considers normal for its business activities. While the Company currently believes that the amount of any reasonably possible loss for known matters would not be material to the Company’s financial condition, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate potential loss could have a material adverse effect on the Company’s financial condition or results of operations in a particular period. The Company has accrued amounts for its loss contingencies which are probable and estimable as of September 29, 2025 and December 30, 2024 and included as a component of other current liabilities. However, these amounts are not material to the consolidated condensed financial statements of the Company. Supplier Finance Program Obligations The Company has agreements with financial institutions to facilitate payments to certain suppliers. Liabilities associated with these agreements are recorded in accounts payable on the consolidated condensed balance sheets and amounted to $ 12,195 and $ 17,218 as of September 29, 2025 and December 30, 2024 , respectively. 19 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Cautionary Statement Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q (Report) contains forward-looking statements regarding future events or our future financial and operational performance. Forward-looking statements include statements regarding markets for our products; trends in net sales, gross profits, and estimated expense levels; liquidity and anticipated cash needs and availability; and any statement that contains the words “anticipate,” “believe,” “plan,” “forecast,” “foresee,” “estimate,” “project,” “expect,” “seek,” “target,” “intend,” “goal,” and other similar expressions. The forward-looking statements included in this Report reflect our current expectations and beliefs, and we do not undertake publicly to update or revise these statements, even if experience or future changes make it clear that any projected results expressed in this Report or future quarterly reports to stockholders, press releases, or company statements will not be realized. In addition, the inclusion of any statement in this Report does not constitute an admission by us that the events or circumstances described in such statement are material. Furthermore, we wish to caution and advise readers that these statements are based on assumptions that may not materialize and may involve risks and uncertainties, many of which are beyond our control, that could cause actual events or performance to differ materially from those contained or implied in these forward-looking statements. These risks and uncertainties include the risks identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024, as updated by our other filings with the SEC, and described elsewhere in this Report. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated condensed financial statements and the related notes and the other financial information included in this Report, as well as the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024, filed with the SEC. COMPANY OVERVIEW We are a leading global manufacturer of technology products, including mission systems, RF components, RF microwave/microelectronic assemblies, and technologically advanced PCBs. We focus on providing time-to-market and volume production of advanced technology products and offer a one-stop design, engineering, and manufacturing solution to our customers. This solution allows us to align technology development with the diverse needs of our customers and to enable them to reduce the time required to develop new products and bring them to market. We serve a diversified customer base consisting of approximately 1,400 customers in various markets throughout the world, including aerospace and defense, data center computing, automotive, medical, industrial, and instrumentation, and networking. Our customers include OEMs, EMS providers, ODMs, distributors, and government agencies (both domestic and allied foreign governments). RECENT DEVELOPMENTS On July 9, 2025, we announced the acquisition of a 750,000-square-foot facility in Eau Claire, Wisconsin, as well as land rights for an additional future manufacturing site in Penang, Malaysia. We believe the Eau Claire, Wisconsin facility comes equipped with the necessary infrastructure to support advanced technology PCB manufacturing and enhances our ability to support future high-volume U.S. production of advanced technology PCBs across key markets, particularly data center computing and networking for generative artificial intelligence (AI) applications. In addition, we acquired land rights for ten acres in Penang to establish a new production site that we anticipate will align with customers’ increasing interests in supply chain diversification beyond China. The future Penang facility will be in close proximity to our existing facility and will enable us to deliver cost-competitive, high-quality advanced technology PCB manufacturing to commercial markets such as data center computing, networking, and medical, industrial, and instrumentation. Together, these new investments support our strategy to offer regionally optimized, globally connected manufacturing solutions for our customers. We previously announced we are in the process of constructing a new advanced technology PCB manufacturing facility in Syracuse, New York. We expect that our new facility will bring advanced technology capability for our domestic high-volume production of ultra‑high‑density interconnect (HDI) PCBs in support of national security requirements. The building construction is complete, equipment is arriving, and we are beginning to install and test equipment setups. Volume production in this facility is expected to commence in the second half of 2026. 20 FINANCIAL OVERVIEW Our customers include both OEMs and EMS providers. We sell to OEMs both directly and indirectly through EMS providers. For such indirect sales, we measure customers based on OEM companies as they are the ultimate end customers. Sales to our ten largest customers collectively accounted for 56% and 55% of our net sales for the quarter and three quarters ended September 29, 2025, respectively. Sales to our ten largest customers collectively accounted for 54% and 53% of our net sales for the quarter and three quarters ended September 30, 2024, respectively. The percentage of our net sales attributable to each of the principal end markets we served was as follows: For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 (1) September 29, 2025 (1) September 30, 2024 (1) End Markets (2) : Aerospace and Defense 45 % 45 % 45 % 46 % Automotive 11 14 11 14 Data Center Computing 23 20 22 20 Medical/Industrial/Instrumentation 14 14 14 14 Networking 7 7 8 6 Total 100 % 100 % 100 % 100 % (1) The end market revenue prior to the quarter ended June 30, 2025 has been recast to reflect certain adjustments to allocations resulting from the segment reorganization. (2) Sales to EMS companies are classified by the end markets of their OEM customers. CRITICAL ACCOUNTING POLICIES AND ESTIMATES Our consolidated condensed financial statements included in this Report have been prepared in accordance with U.S. GAAP. The preparation of these consolidated condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities. See Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations , in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024 for further discussion of critical accounting policies and estimates. There have been no material changes to our critical accounting policies and estimates since December 30, 2024. CONSOLIDATED OPERATING RESULTS Net sales consist of gross sales less an allowance for returns, which typically have been approximately 2% of gross sales. We provide our customers a limited right of return for defective PCBs including components, assemblies, and subsystems. We record an estimate for sales returns and allowances at the time of sale based on historical results and anticipated returns. Selected financial highlights are presented in the table below: For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (In thousands, except margin rates) Net sales $ 752,736 $ 616,538 $ 2,132,025 $ 1,791,788 Cost of goods sold 596,000 486,650 1,696,208 1,440,954 Gross profit 156,736 129,888 435,817 350,834 Gross margin 20.8 % 21.1 % 20.4 % 19.6 % Operating expenses: Selling and marketing 21,796 19,961 64,383 60,053 General and administrative 48,598 42,567 142,091 124,841 Research and development 7,038 8,054 22,111 23,922 Amortization of definite-lived intangibles 6,889 6,951 20,666 28,636 Restructuring charges 509 1,393 2,631 6,367 Total operating expenses 84,830 78,926 251,882 243,819 Operating income 71,906 50,962 183,935 107,015 Operating margin 9.6 % 8.3 % 8.6 % 6.0 % Total other expense, net (10,093 ) (25,945 ) (35,606 ) (37,397 ) Income tax provision (8,758 ) (10,706 ) (21,566 ) (18,489 ) Net income $ 53,055 $ 14,311 $ 126,763 $ 51,129 The following discussion and analysis is for the quarter and three quarters ended September 29, 2025, compared to the quarter and three quarters ended September 30, 2024, unless otherwise stated. 21 Net Sales Total net sales increased $136.2 million, or 22.1%, to $752.7 million for the quarter ended September 29, 2025, from $616.5 million for the quarter ended September 30, 2024. The primary driver of this increase was strong demand in our aerospace and defense, data center computing, and networking end markets, the latter two being driven by generative AI. In addition, our medical, industrial, and instrumentation end market was also stronger as inventories and demand have normalized in this end market. Total net sales increased $340.2 million, or 19.0%, to $2,132.0 million for the three quarters ended September 29, 2025, from $1,791.8 million for the three quarters ended September 30, 2024. The primary drivers of the increase were as discussed in the paragraph above. Gross Profit and Margin Rate Gross profit increased $26.8 million to $156.7 million for the quarter ended September 29, 2025, from $129.9 million for the quarter ended September 30, 2024, primarily due to higher sales. Gross margin rate decreased slightly to 20.8% for the quarter ended September 29, 2025, from 21.1% for the quarter ended September 30, 2024. This decrease was primarily due to ramp‑up costs incurred in the third quarter of 2025 in connection with our fabrication plant in Penang, Malaysia as compared to the third quarter of 2024. Gross profit increased $85.0 million to $435.8 million for the three quarters ended September 29, 2025, from $350.8 million for the three quarters ended September 30, 2024, primarily due to higher sales. Gross margin rate increased to 20.4% for the three quarters ended September 29, 2025, from 19.6% for the three quarters ended September 30, 2024. The increase was primarily due to improved operational execution, favorable product mix, and increased volume of PCB shipments as compared to the same period of 2024. Operating Expenses Operating expenses increased $5.9 million to $84.8 million for the quarter ended September 29, 2025, from $78.9 million for the quarter ended September 30, 2024, primarily due to higher incentive compensation expense, stock-based compensation, and outside services costs. Operating expenses increased $8.1 million to $251.9 million for the three quarters ended September 29, 2025, from $243.8 million for the three quarters ended September 30, 2024, primarily due to the absence of gains on the sale of assets primarily related to the sale of two buildings vacated with the closure of our Anaheim and Santa Clara plants of $14.4 million that occurred in the three quarters ended September 30, 2024, partially offset by the write down of our Hong Kong building of $6.1 million that occurred in the three quarters ended September 30, 2024. In addition, increased stock-based compensation and incentive compensation expense contributed to the higher operating expenses, partially offset by a decrease in amortization of definite-lived intangibles. Operating Income and Margin Rate Operating income increased $20.9 million to $71.9 million for the quarter ended September 29, 2025, from $51.0 million for the quarter ended September 30, 2024. Operating margin rate increased to 9.6% for the quarter ended September 29, 2025, from 8.3% for the quarter ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses . Operating income increased $76.9 million to $183.9 million for the three quarters ended September 29, 2025, from $107.0 million for the three quarters ended September 30, 2024. Operating margin rate increased to 8.6% for the three quarters ended September 29, 2025, from 6.0% for the three quarters ended September 30, 2024. The primary drivers of these increases are discussed above in the variance explanations for Gross Profit and Margin Rate and Operating Expenses . Total Other Expense, Net Total other expense, net decreased $15.9 million to $10.1 million for the quarter ended September 29, 2025, from $25.9 million for the quarter ended September 30, 2024, primarily as a result of lower unrealized foreign exchange losses during the quarter ended September 29, 2025. We utilize the Chinese Renminbi (RMB) and Malaysian Ringgit (MYR) at our China and Malaysia facilities, respectively, for employee‑related and other costs of running our operations in foreign countries. There was an unrealized loss from foreign exchange of $0.5 million during the quarter ended September 29, 2025, compared to $16.2 million during the quarter ended September 30, 2024. This unrealized loss was related to the translation of our China and Malaysia balance sheets from their local currencies into the U.S. dollar functional currency, resulting from weakening RMB and MYR during the quarter ended September 29, 2025 as compared to the quarter ended September 30, 2024. Total other expense, net decreased $1.8 million to $35.6 million for the three quarters ended September 29, 2025, from $37.4 million for the three quarters ended September 30, 2024, primarily as a result of lower unrealized foreign exchange losses during the three quarters ended September 29, 2025. There was an unrealized loss from foreign exchange of $8.5 million during the three quarters ended September 29, 2025, compared to $12.0 million during the three quarters ended September 30, 2024. This decrease was primarily due to the foreign currency impacts discussed in the paragraph above. 22 Income Taxes Income tax expense decreased $1.9 million to $8.8 million for the quarter ended September 29, 2025, from $10.7 million for the quarter ended September 30, 2024, primarily due to the OBBBA tax impact, as discussed below, and an income tax benefit from the deduction of stock-based compensation, partially offset by accruals for potential assessments and uncertain tax positions in various jurisdictions. Income tax expense increased $3.1 million to $21.6 million for the three quarters ended September 29, 2025, from $18.5 million for the three quarters ended September 30, 2024, primarily due to an increase in income before income taxes for the three quarters ended September 29, 2025 and income tax accruals for potential assessments and uncertain tax positions in various jurisdictions, partially offset by the OBBBA tax impact, as discussed below, and an income tax benefit from the deduction of stock‑based compensation. On July 4, 2025, the OBBBA was enacted, introducing amendments to U.S. tax laws with various effective dates from 2025 to 2027. The OBBBA includes provisions such as the permanent extension of certain provisions of the Tax Cuts and Jobs Act that were set to expire at the end of 2025 and modifications to the international tax framework. Topic 740 requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. Accordingly, our tax provisions for the quarter and three quarters ended September 29, 2025 incorporated the estimated effects of the tax law changes including the accelerated depreciation of qualified property and the immediate expensing of U.S. research and development expenditure paid or incurred for tax years beginning after December 31, 2024. We recorded a $5.2 million benefit from the decrease in the U.S. valuation allowance resulting from the OBBBA impact to our deferred tax assets. Our effective tax rate is primarily impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits and deductions available to us as well as changes in valuation allowances and certain non-deductible items. We had a net deferred income tax liability of $41.9 million and $40.4 million as of September 29, 2025 and September 30, 2024, respectively. 23 SEGMENT OPERATING RESULTS Basis of Presentation During the quarter ended June 30, 2025, in connection with our change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, our management finalized its assessment of our operating segments and concluded that we now have three reportable segments: A&D, Commercial, and RF&S Components. As a result, certain prior period amounts have been reclassified to conform with this new presentation. See Part I, Item 1, Note 4, Segment Information , of the Notes to Consolidated Condensed Financial Statements in this Report for further information. Selected segment financial highlights, with reconciliations to operating income, are presented in the table below: For the Quarter Ended For the Three Quarters Ended September 29, 2025 September 30, 2024 September 29, 2025 September 30, 2024 (In thousands, except margin rates) Segment sales: A&D $ 336,841 $ 279,533 $ 974,553 $ 833,798 Commercial 408,920 329,382 1,137,249 936,440 RF&S Components 10,444 9,780 29,342 27,196 Total $ 756,205 $ 618,695 $ 2,141,144 $ 1,797,434 Segment operating income: A&D $ 52,884 $ 40,279 $ 138,943 $ 100,252 Commercial 60,031 51,105 163,749 130,858 RF&S Components 3,126 2,426 7,581 6,139 Total 116,041 93,810 310,273 237,249 Segment operating margin rate: A&D 15.7 % 14.4 % 14.3 % 12.0 % Commercial 14.7 % 15.5 % 14.4 % 14.0 % RF&S Components 29.9 % 24.8 % 25.8 % 22.6 % Total 15.3 % 15.2 % 14.5 % 13.2 % Unallocated amounts: Restructuring (509 ) (1,393 ) (2,631 ) (6,367 ) Gain on sale of property, plant, and equipment — — — 14,420 Acquisition-related and other charges (15 ) (2,867 ) (15 ) (12,939 ) Stock-based compensation (11,611 ) (8,330 ) (29,586 ) (21,697 ) Other corporate expenses (22,775 ) (20,972 ) (66,433 ) (68,009 ) Amortization of definite-lived intangibles (1) (9,225 ) (9,286 ) (27,673 ) (35,642 ) Operating income $ 71,906 $ 50,962 $ 183,935 $ 107,015 (1) Amortization of definite-lived intangibles relates to the A&D, Commercial, and RF&S Components reportable segments, but is not reviewed separately by the CODM. For the quarter and three quarters ended September 29, 2025, amortization expense of $2,336 and $7,007, respectively, is included in cost of goods sold for the A&D reportable segment. For the quarter and three quarters ended September 30, 2024, amortization expense of $2,335 and $7,006, respectively, is included in cost of goods sold for the A&D reportable segment. Segment operating income, as reconciled in Part I, Item 1, Note 4, Segment Information , of the Notes to Consolidated Condensed Financial Statements in this Report, and segment operating margin rate (segment operating income divided by segment sales) are presented in conformity with Accounting Standards Codification (ASC) Topic 280, Segment Reporting . These measures are reported to the CODM, who is the President and Chief Executive Officer, for purposes of making decisions about allocating resources to the segments and assessing their performance. For these reasons, these measures are excluded from the definition of non‑GAAP financial measures under the SEC's Regulation G and Item 10(e) of Regulation S-K. A&D Segment Sales Segment sales for the A&D reportable segment increased $57.3 million, or 20.5%, to $336.8 million for the quarter ended September 29, 2025, from $279.5 million for the quarter ended September 30, 2024. The primary drivers of this increase were improved spending in previous defense budgets, our strong strategic program alignment, and key bookings for ongoing franchise programs, 24 including restricted programs. These increases were driven by increased sales related to missiles and munitions as well as strong demand in our mission systems and specialty assembly businesses. Segment sales for the A&D reportable segment increased $140.8 million, or 16.9%, to $974.6 million for the three quarters ended September 29, 2025, from $833.8 million for the three quarters ended September 30, 2024. The primary drivers of the increase were as discussed in the paragraph above. Segment Operating Income and Margin Rate Segment operating income for the A&D reportable segment increased $12.6 million to $52.9 million for the quarter ended September 29, 2025, from $40.3 million for the quarter ended September 30, 2024. Segment operating margin rate for the A&D reportable segment increased to 15.7% for the quarter ended September 29, 2025, from 14.4% for the quarter ended September 30, 2024. The primary drivers of these increases were higher sales volume, as discussed above, favorable product mix, and improved operational execution. Segment operating income for the A&D reportable segment increased $38.7 million to $138.9 million for the three quarters ended September 29, 2025, from $100.3 million for the three quarters ended September 30, 2024. Segment operating margin rate for the A&D reportable segment increased to 14.3% for the three quarters ended September 29, 2025, from 12.0% for the three quarters ended September 30, 2024. The primary drivers of these increases were higher sales volume, as discussed above, favorable product mix, and improved operational execution. Commercial Segment Sales Segment sales for the Commercial reportable segment increased $79.5 million, or 24.1%, to $408.9 million for the quarter ended September 29, 2025, from $329.4 million for the quarter ended September 30, 2024. The primary driver of this increase was strong demand in our data center computing and networking end markets driven by generative AI. Segment sales for the Commercial reportable segment increased $200.8 million, or 21.4%, to $1,137.2 million for the three quarters ended September 29, 2025, from $936.4 million for the three quarters ended September 30, 2024. The primary driver of this increase was strong demand in our data center computing and networking end markets driven by generative AI, as well as normalized demand and increased AI-related demand in our medical, industrial, and instrumentation end market. Segment Operating Income and Margin Rate Segment operating income for the Commercial reportable segment increased $8.9 million to $60.0 million for the quarter ended September 29, 2025, from $51.1 million for the quarter ended September 30, 2024. Segment operating margin rate for the Commercial reportable segment decreased to 14.7% for the quarter ended September 29, 2025, from 15.5% for the quarter ended September 30, 2024. The primary driver of the increase in segment operating income was higher sales volume as discussed above, while the segment operating margin rate decreased due to increased ramp-up costs in connection with our fabrication plant in Penang, Malaysia, as well as product mix change. Segment operating income for the Commercial reportable segment increased $32.9 million to $163.7 million for the three quarters ended September 29, 2025, from $130.9 million for the three quarters ended September 30, 2024. Segment operating margin rate for the Commercial reportable segment increased to 14.4% for the three quarters ended September 29, 2025, from 14.0% for the three quarters ended September 30, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution. RF&S Components Segment Sales Segment sales for the RF&S Components reportable segment increased $0.7 million, or 6.8%, to $10.4 million for the quarter ended September 29, 2025, from $9.8 million for the quarter ended September 30, 2024. The primary driver of this increase was stronger demand across the networking and medical, industrial, and instrumentation end markets. Segment sales for the RF&S Components reportable segment increased $2.1 million, or 7.9%, to $29.3 million for the three quarters ended September 29, 2025, from $27.2 million for the three quarters ended September 30, 2024. The primary driver of this increase was stronger demand across the networking and medical, industrial, and instrumentation end markets. Segment Operating Income and Margin Rate Segment operating income for the RF&S Components reportable segment increased $0.7 million to $3.1 million for the quarter ended September 29, 2025, from $2.4 million for the quarter ended September 30, 2024. Segment operating margin rate for the RF&S Components reportable segment increased to 29.9% for the quarter ended September 29, 2025, from 24.8% for the quarter ended 25 September 30, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution. Segment operating income for the RF&S Components reportable segment increased $1.4 million to $7.6 million for the three quarters ended September 29, 2025, from $6.1 million for the three quarters ended September 30, 2024. Segment operating margin rate for the RF&S Components reportable segment increased to 25.8% for the three quarters ended September 29, 2025, from 22.6% for the three quarters ended September 30, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution. Liquidity and Capital Resources Our principal sources of liquidity have been cash provided by operations, the issuance of debt, and borrowings under our revolving credit facilities. Our principal uses of cash have been to finance capital expenditures, finance acquisitions, fund working capital requirements, repay debt obligations, and repurchase common stock. We anticipate that financing capital expenditures, financing acquisitions, funding working capital requirements, servicing debt, and repurchasing common stock will be the principal demands on our cash in the future. Cash flow provided by operating activities during the first three quarters of 2025 was $229.0 million as compared to cash flow provided by operating activities of $150.8 million in the same period in 2024. The increase in cash flow was primarily due to an increase in net income of $75.6 million. Net cash used in investing activities during the first three quarters of 2025 was $222.7 million, primarily resulting from the use of $223.2 million for net purchases of property, plant, and equipment and other assets. Net cash used in investing activities during the first three quarters of 2024 was $93.4 million, primarily resulting from the use of $129.7 million for purchases of property, plant, and equipment and other assets. This was partially offset by the receipt of $29.6 million of proceeds from the sale of property, plant, and equipment and other assets primarily related to the sale of two buildings vacated by the closure of our Anaheim and Santa Clara plants and $6.7 million of proceeds from the sale of property associated with our Shanghai E‑MS subsidiary. Net cash used in financing activities during the first three quarters of 2025 was $19.2 million, reflecting the use of $17.9 million for repurchases of our common stock and $2.8 million for the repayment of long-term debt borrowings, less customer deposits of $1.5 million. Net cash used in financing activities during the first three quarters of 2024 was $38.2 million, reflecting the use of $34.5 million for repurchases of common stock, $8.7 million for the repayment of long-term debt borrowings, and $1.1 million for payment of debt issuance costs, partially offset by $6.1 million of proceeds from long-term debt borrowings related to the refinancing of our Term Loan Facility. As of September 29, 2025, we had cash and cash equivalents of approximately $491.1 million, of which approximately $196.6 million was held by our foreign subsidiaries, primarily in China, and $199.4 million of available borrowing capacity under our revolving credit facilities. Should we choose to remit cash to the United States from our foreign locations, we may incur tax obligations which would reduce the amount of cash ultimately available to the United States. However, we believe there would be no material tax expenses not previously accrued for the repatriation of this cash. Our total 2025 capital expenditures are expected to be in the range of $265.0 million to $285.0 million, of which approximately $54.0 million relate to construction of our new plant in Syracuse, New York. Share Repurchases On May 8, 2025, our Board of Directors authorized the 2025 Repurchase Program, under which we may repurchase up to $100.0 million in value of our common stock from time to time through May 7, 2027. We did not repurchase any shares of our common stock during the quarter ended September 29, 2025. During the three quarters ended September 29, 2025, under our previous two-year repurchase program that expired on May 3, 2025, we repurchased approximately 0.7 million shares of our common stock for a total cost of $17.9 million (including commissions). As of September 29, 2025, the remaining amount in value available to be repurchased under the 2025 Repurchase Program was $100.0 million. Long-term Debt and Letters of Credit As of September 29, 2025, we had $916.6 million of outstanding debt, net of discount and issuance costs, composed of $497.2 million of Senior Notes due 2029, $337.4 million under the Term Loan Facility, $80.0 million under the Asia ABL, and $2.1 million of other loans. Pursuant to the terms of the Senior Notes due 2029 and Term Loan Facility, we are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments. Under the ABL Revolving Loans, we are also subject to various financial covenants, including leverage and fixed-charge coverage ratios. As of September 29, 2025, we were in compliance with the covenants under the Senior Notes due 2029, Term Loan Facility, and ABL Revolving Loans. 26 Based on our current level of operations, we believe that cash generated from operations, cash on hand, and cash from the issuance of term and revolving debt will be adequate to meet our currently anticipated capital expenditure, debt service, and working capital needs for the next 12 months. Additional information regarding our indebtedness, including information about the credit available under our debt facilities, interest rates, and other key terms of our outstanding indebtedness, is included in Part I, Item 1, Note 7, Long‑term Debt and Letters of Credit , of the Notes to Consolidated Condensed Financial Statements included in this Report. Supplier Finance Program Obligations We have agreements with financial institutions to facilitate payments to certain suppliers. Liabilities associated with these agreements are recorded in accounts payable on the consolidated condensed balance sheets and amounted to $12.2 million and $17.2 million as of September 29, 2025 and December 30, 2024, respectively. Contractual Obligations and Commitments As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments. These obligations impact our liquidity and capital resource needs. Our estimated future obligations consist of long-term debt obligations, interest on debt obligations, derivative liabilities, purchase obligations, and leases. As of September 29, 2025, there were no material changes outside the ordinary course of business since December 30, 2024 to our contractual obligations and commitments and the related cash requirements. Seasonality We tend to experience modest seasonal softness in the first and third quarters due to holidays and vacation periods in China and North America, respectively, which limit production leading to stronger revenue levels in the second and fourth quarters. Recently Issued Accounting Standards For a description of recently adopted and issued accounting standards, including the respective dates of adoption and the expected effects on our results of operations and financial condition, see Part I, Item 1, Note 1, Nature of Operations and Basis of Presentation , of the Notes to Consolidated Condensed Financial Statements included in this Report. Item 3. Quantitative and Qualitati ve Disclosures About Market Risk There have been no material changes to our risks as previously disclosed in Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024. Item 4. Controls and Procedures Evaluation of Disclosure Controls and Procedures Our management, under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of September 29, 2025 such disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Changes in Internal Control over Financial Reporting We continue to expand our implementation of an enterprise resource planning (ERP) system on a worldwide basis, which is expected to improve the efficiency of the financial reporting and related transaction processes. We have completed the implementation at certain locations and as a result, we made changes to our processes and procedures which, in turn, resulted in changes to our internal control over financial reporting, including the implementation of additional controls. We are in the process of rolling out the ERP system to our remaining locations to standardize the ERP system. There were no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 29, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 27 PART II. OTHER INFORMATION Item 1. Legal Proceedings From time to time, we may become a party to various legal proceedings arising in the ordinary course of our business. There can be no assurance that we will prevail in any such litigation. We believe that the amount of any reasonably possible or probable loss for known matters would not be material to our financial statements; however, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate potential loss could have a material adverse effect on our financial condition, results of operations, or cash flows in a particular period. Item 1A. Ri sk Factors There have been no material changes in our risk factors as previously disclosed in Part I, Item 1A, Risk Factors , of our Annual Report on Form 10-K for the fiscal year ended December 30, 2024. Item 2. Unre gistered Sales of Equity Securities and Use of Proceeds Issuer Purchases of Equity Securities On May 8, 2025, our Board of Directors authorized a new share repurchase program, under which we may repurchase up to $100.0 million in value of our outstanding shares of common stock from time to time through May 7, 2027. Our previous two-year repurchase program expired on May 3, 2025. We did not repurchase any shares of our common stock during the quarter ended September 29, 2025. Item 3. Defaults Upon Senior Securities Not applicable. Item 4 . Mine Safety Disclosures Not applicable. Item 5. Other Information Rule 10b5-1 Trading Plans During the quarter ended September 29, 2025, our directors and/or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions, or written plans for the purchase or sale of our securities set forth in the table below. Name and Title Action Adoption / Termination Date Rule 10b5-1 (1) Non-Rule 10b5-1 (2) Total Number of Shares of Common Stock to be Sold (3) Expiration Date Daniel L. Boehle ( Executive Vice President and CFO ) Adoption August 8, 2025 X Indeterminable (4) August 31, 2026 Thomas Clapprood ( President, Radar Systems and Sensors Business Unit) Adoption August 27, 2025 X Indeterminable (4) June 30, 2026 Thomas T. Edman ( Director ) Adoption August 20, 2025 X Indeterminable (4) June 30, 2026 Thomas T. Edman ( Director ) Adoption August 25, 2025 X Up to 84,000 May 29, 2026 Robert Farrell ( President, Communication and Computing Business Unit ) Adoption August 15, 2025 X Indeterminable (4) June 30, 2026 Catherine A. Gridley ( Executive Vice President and President, Aerospace & Defense Sector ) Adoption August 27, 2025 X Indeterminable (4) June 30, 2026 Dale Knecht ( Senior Vice President of Global Information Technology ) Adoption August 8, 2025 X Indeterminable (4) June 30, 2026 Shawn Powers ( Executive Vice President and Chief Human Resources Officer ) Adoption August 29, 2025 X Indeterminable (4) June 30, 2026 28 Name and Title Action Adoption / Termination Date Rule 10b5-1 (1) Non-Rule 10b5-1 (2) Total Number of Shares of Common Stock to be Sold (3) Expiration Date Shawn Powers ( Executive Vice President and Chief Human Resources Officer ) Adoption August 29, 2025 X Up to 15,000 November 30, 2026 Douglas L. Soder ( Executive Vice President and President, Commercial Sector ) Adoption August 21, 2025 X Up to 25,000 November 30, 2026 Douglas L. Soder ( Executive Vice President and President, Commercial Sector ) Adoption August 21, 2025 X Indeterminable (4) June 30, 2026 Steven Spoto ( President, Integrated Electronics Business Unit ) Adoption August 22, 2025 X Indeterminable (4) August 12, 2026 James P. Walsh ( Chief Operating Officer ) Adoption August 11, 2025 X Indeterminable (4) June 30, 2026 Daniel J. Weber ( Executive Vice President, Chief Legal Officer and Secretary ) Adoption August 6, 2025 X Indeterminable (4) June 30, 2026 (1) Contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. (2) “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. (3) Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the trading plan. (4) Rule 10b5-1 trading arrangement that is intended to provide for “eligible sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from vesting of RSUs or PRUs. The number of shares subject to covered RSUs or PRUs that will be sold to satisfy applicable tax withholding obligations upon vesting is not currently determinable as the number will vary based on the market price of our common stock and the extent to which vesting conditions are satisfied. This sell-to-cover arrangement provides solely for the automatic sale of shares that would otherwise be issuable in respect of a covered RSU or PRU in an amount sufficient to satisfy the applicable withholding obligation, with the proceeds of the sale delivered to the Company in satisfaction of the applicable withholding obligation. 29 Item 6. Exhibits Exhibit Filed/Furnished Incorporated by Reference Number Exhibit Description Herewith Form File Number Exhibit Filing Date 10.1 Letter Agreement, dated as of August 14, 2025, by and between the Company and Edwin Roks 8-K 000-31285 10.1 August 14, 2025 10.2 Form of First Amendment to Performance-Based RSU Grant Notice Award Agreement by and between TTM Technologies, Inc. and Thomas Edman 8-K 000-31285 10.2 August 14, 2025 31.1 CEO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 CFO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1* CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 32.2* CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) Management contract or compensatory plan. * Furnished herewith. The certifications attached as Exhibits 32.1 and 32.2 that accompany this Report are not deemed filed with the Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing. 30 SIGNAT URES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. TTM Technologies, Inc. /s/ Daniel L. Boehle Dated: October 31, 2025 Daniel L. Boehle Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer and duly authorized signatory) 31